0001437749-21-011821.txt : 20210512 0001437749-21-011821.hdr.sgml : 20210512 20210512154544 ACCESSION NUMBER: 0001437749-21-011821 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 44 CONFORMED PERIOD OF REPORT: 20210331 FILED AS OF DATE: 20210512 DATE AS OF CHANGE: 20210512 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OCULUS VISIONTECH INC. CENTRAL INDEX KEY: 0001107280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 061576391 STATE OF INCORPORATION: WY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-29651 FILM NUMBER: 21914924 BUSINESS ADDRESS: STREET 1: 837 WEST HASTINGS STREET STREET 2: SUITE 507 CITY: VANCOUVER STATE: A1 ZIP: V6C 3N6 BUSINESS PHONE: 6046851017 MAIL ADDRESS: STREET 1: 837 WEST HASTINGS STREET STREET 2: SUITE 507 CITY: VANCOUVER STATE: A1 ZIP: V6C 3N6 FORMER COMPANY: FORMER CONFORMED NAME: OCULUS VISION TECH INC. DATE OF NAME CHANGE: 20120201 FORMER COMPANY: FORMER CONFORMED NAME: USA VIDEO INTERACTIVE CORP DATE OF NAME CHANGE: 20000217 10-Q 1 ovtz20210331_10q.htm FORM 10-Q ovtz20210331_10q.htm
 
 

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☑QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2021

 

 

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _____ to _____

 

Commission File Number: 0-29651

 

OCULUS VISIONTECH INC.

(Exact name of registrant as specified in its charter)

 

Wyoming

06-1576391

(State or Other Jurisdiction of

(I.R.S. Employer

Incorporation or Organization)

Identification No.)

 

Suite 507 - 837 West Hastings Street, Vancouver, BC, Canada, V6C 3N6

(Address of principal executive offices) (Zip code)

 

(604) 685-1017

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

 

Yes   ☑      No   ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

 

Yes    ☑      No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” ‘‘accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

Non-accelerated filer     

Smaller reporting company   

    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

Yes    ☐      No ☑

 

As at May 12, 2021, there were 91,422,569 shares of the registrant’s common stock outstanding

 

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

Trading Symbol(s)

Name of each exchange on which registered

Common

   

Common stock - no par value

OVTZ

Over The Counter Bulletin Board

Preferred stock - no par value

N/A

N/A

Common stock - no par value

OVT

TSX Venture Exchange

Common stock - no par value

USF1

Frankfurt Stock Exchange

 

 

 

TABLE OF CONTENTS

 

    PART I  FINANCIAL INFORMATION  
   

Forward Looking Statements

4

Item 1.  

 

Financial Statements

6

   

Condensed Interim Consolidated Balance Sheets

6

 

(A)

Condensed Interim Consolidated Statements of Operations

7

 

(B)

Condensed Interim Consolidated Statements Of Stockholders’ Equity (Deficiency) 

8

 

(C)

Condensed Interim Consolidated Statements of Cash Flows

9

 

(D)

Notes to Condensed Interim Consolidated Financial Statements

10

Item 2.  

(E)

Management’s Discussion and Analysis of Financial Condition and Results of Operations

13

Item 3.

 

Quantitative and Qualitative Disclosures About Market Risk

17

Item 4.

 

Controls and Procedures

17

     

 

   

PART II  OTHER INFORMATION

 
       

Item 1.  

 

Legal Proceedings

18

Item 1A.

 

Risk Factors

18

Item 2.     

 

Unregistered Sales of Equity Securities and Use of Proceeds

18

Item 3.

 

Defaults Upon Senior Securities

18

Item 4.

 

Mine Safety Disclosure

18

Item 5.

 

Other Information

18

Item 6.

 

Exhibits

18

 

 

FORWARD LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q contains forward-looking statements. All statements other than statements of historical fact are “forward-looking statements” for the purposes of this Quarterly Report on Form 10-Q. In some cases, you can identify these statements by forward-looking words such as “plan”, “may”, “will”, “expect”, “intend”, “anticipate”, believe”, “estimate” and “continue” or similar words. Forward-looking statements are statements that are not historical facts, and include, but are not limited to:

 

statements regarding our products and services, including:

 

o

our digital watermarking technology and Cloud-based document protection system;

 

o

our data privacy and data protection services and solutions; o our technology, our cash needs, including our ability to fund our future capital expenditures and working capital requirements;

 

o

our expectations regarding competition and growth in our sector; o the future sources and availability of additional funding; and

 

o

the effect of funding arrangements on projects and products.

 

You should read statements that contain these words carefully because they discuss future expectations and plans, which contain projections of future results of operations or financial condition or state other forward-looking information. We believe that it is important to communicate future expectations to investors. However, there may be events in the future that we are not able to accurately predict or control. Accordingly, we do not undertake any obligation to update any forward-looking statements for any reason, even if new information becomes available or other events occur in the future, except as required by law.

 

Forward-looking statements are based on current expectations about future events affecting the Company and are subject to uncertainties and factors that affect all business operating in a global market as well as matters specific to the Company. These uncertainties and factors are difficult to predict, and many of them are beyond the Company’s control. Factors to consider when evaluating these forward-looking statements include, but are not limited to:

 

 

the impact of pandemics;

 

the Company’s limited operating history makes it difficult to evaluate its business and prospects;

 

the Company has incurred substantial losses and expects to incur losses in the future and may never achieve profitability;

 

if the Company is unable to obtain substantial additional financing, it may not be able to remain in business;

 

the Company’s operating results in future periods are expected to be subject to significant fluctuations, which would likely affect the trading price of the Company’s common shares;

 

the data privacy and data protection markets are highly competitive, and the Company’s failure to successfully compete will limit its ability to attain, retain and increase its market share;

 

the document protection market is highly competitive, and the Company’s failure to compete successfully would limit its ability to retain and increase its market share;

 

the video digital watermarking business is highly competitive, and the Company’s failure to compete successfully would limit its ability to retain and increase its market share;

 

the Company is subject to rapid technological change, which could render its products and services obsolete;

 

the Company is dependent upon vendors and other third-party service providers and will be competing with some of these companies;

 

the Company’s services are technically complex and it may not be able to prevent defects that could decrease their market acceptance, result in product liability or harm its reputation;

 

any loss of the Company’s personnel or inability to acquire new personnel could harm its business;

 

failure to maintain effective internal controls in accordance with Section 404 of the Sarbanes-Oxley Act could have material adverse effect on the Company’s business and operating results and shareholders could lose confidence in the Company’s financial reporting;

 

the Company does not currently have any paying customers;

 

the Company’s business may suffer if it cannot protect its intellectual property;

 

the Company’s products may infringe the intellectual property rights of others, causing the Company to incur significant costs or prevent us from licensing its products;

 

the Company’s success depends on the continued growth in demand for e-business applications;

 

government regulation and legal uncertainties could add additional costs and risks to doing business on the Internet;

 

the Company’s share price has been and could be highly volatile, which could result in substantial losses to investors;

 

the Company has not paid cash dividends in the past and does not expect to pay cash dividends in the foreseeable future.

 

 

Any return on investment may be limited to the value of the Company’s common shares;

 

securities analysts may not initiate coverage or continue to cover the Company’s common shares, and this may have a negative impact on its market price;

 

anti-takeover provisions in our charter documents could prevent or delay a change in control of the Company; LEGAL_36260802.1

 

the Company intends to issue additional equity securities, which may dilute the interests of current shareholders or carry rights or preferences senior to the common shares;

 

the exercise of options and warrants and other issuances of common shares or securities convertible into or exercisable for common shares will dilute the ownership interest of the Company’s current shareholders and may adversely affect the future market price of the Company’s common shares;

 

limited liability of executive officers and directors may discourage shareholders from bringing a lawsuit against them;

 

requirements of the SEC with regard to low-priced “penny stocks” may adversely affect the ability of shareholders to sell their shares in the secondary market;

 

the Company does not anticipate paying dividends to shareholders in the foreseeable future;

 

the Company may be exposed to adverse currency exchange rate fluctuations, which could harm the Company’s financial results and cash flows;

 

service outages and disruption of the Company’s infrastructure may harm the Company and adversely impact business operations and injure reputation;

 

security vulnerabilities in the Company’s products and services or any breach of the Company’s security measures may injure its reputation and disrupt the Company’s business;

 

the financial reporting obligations of being a public company in the United States are expensive, time consuming, and may place significant demands on the Company’s management; and

 

the Company’s failure to manage or adequately address any one or more of these risks could result in the business suffering a material adverse effect.

 

The Company believes the items outlined above are important factors that could cause estimates included in its financial statements to differ materially from the actual results and those expressed in a forward-looking statement made in this report or elsewhere by the Company or on its behalf. The Company has discussed these factors in more detail under “Risk Factors” in its Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and other periodic reports filed with the United States Securities and Exchange Commission (“SEC”). Accordingly, to the extent that this quarterly report contains forward-looking statements regarding the financial condition, operating results, business prospects or any other aspect of the Company, please be advised that the Company’s actual financial condition, operating results and business performance may differ materially from that projected or estimated by the Company in forward-looking statements. We do not intend to update our description of important factors each time a potential important factor arises, except as required by applicable securities laws and regulations. We advise our shareholders that they should (i) be aware that factors not referred to above could affect the accuracy of the Company’s forward-looking statements and (ii) use caution when considering the Company’s forward-looking statements.

 

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

CONDENSED INTERIM CONSOLIDATED BALANCE SHEETS

(Stated in US Dollars)

(Unaudited)

 


 

   

March 31,

   

December 31,

 
   

2021

   

2020

 
   

(unaudited)

   

(audited)

 

ASSETS

               
                 

Current Assets:

               

Cash and cash equivalents

  $ 298,611     $ 490,190  

Prepaid expenses and other current assets

    2,801       6,082  

Total Assets

  $ 301,412     $ 496,272  
                 

LIABILITIES AND STOCKHOLDERS' EQUITY

               
                 

Current Liabilities:

               

Accounts payable and accrued expenses

  $ 53,578     $ 32,329  

Accounts payable and accrued expenses - related parties

    135,759       135,738  

Total current liabilities

    189,337       168,067  
                 

Commitments and Contingencies

    -       -  
                 

Stockholders' Equity:

               

Preferred stock - no par value; authorized 250,000,000 shares, none issued

               

Common stock and additional paid-in capital - no par value; authorized 500,000,000 shares, issued and outstanding 86,522,569 and 86,522,569

    44,250,747       44,073,257  

Commitment to issue shares

    414,128       414,128  

Accumulated deficit

    (44,552,800

)

    (44,159,180

)

Stockholders' equity

    112,075       328,205  

Total Liabilities and Stockholders' Equity

  $ 301,412     $ 496,272  

 

SEE ACCOMPANYING NOTES

 

 

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF OPERATIONS

(Stated in US Dollars)

(Unaudited)

 


 

Three months ended March 31,

 

2021

   

2020

 
                 

Revenue

  $ -     $ -  
                 

Expenses:

               

Research and development

    132,724       1,577  

Selling, general and administrative

    83,406       71,788  

Stock-based compensation (Note 7)

    177,490       -  
                 

Total expenses

    393,620       73,365  

Loss from operations

    (393,620 )     (73,365 )
                 

Other income

               

Interest income

    -       96  
      -       96  
                 

Net loss

  $ (393,620 )   $ (73,269 )
                 

Net loss per share - basic and diluted

  $ (0.00 )   $ (0.00 )
                 

Weighted average number of common shares outstanding – basic and diluted

    86,522,569       67,022,568  

 

SEE ACCOMPANYING NOTES

 

 

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(Stated in US Dollars)

(Unaudited)

 


 

   

Common Stock and

                         
   

Additional Paid in

                         
   

Capital

                         
                   

Commitment to

   

Accumulated

   

Stockholders'

 
    Shares    

Amount

   

Issue Shares

   

Deficit

   

Equity

 
                                         
                                         

Balance at January 1, 2020

    67,022,568     $ 41,634,999     $ -     $ (41,386,696 )   $ 248,303  
                                         

Net loss

    -       -       -       (73,269 )     (73,269 )
                                         

Balance at March 31, 2020

    86,522,569     $ 44,073,257     $ 414,128     $ (41,459,965 )   $ 175,034  
                                         

Balance at January 1, 2021

    86,522,569     $ 44,073,257     $ 414,128     $ (44,159,180 )   $ 328,205  
                                         

Share-based compensation

    -       177,490       -       -       177,490  

Net loss

    -       -       -       (393,620 )     (393,620 )
                                         

Balance at March 31, 2021

    86,522,569     $ 44,250,747     $ 414,128     $ (44,552,800 )   $ 112,075  

 

 

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Stated in US Dollars)

(Unaudited)

 


 

Three months ended March 31,

 

2021

   

2020

 
                 

Cash flows from operating activities:

               

Net loss

  $ (393,620

)

  $ (73,269

)

Add back non-cash share-based compensation

    177,490       -  

Adjustments to reconcile net loss to net cash used in operating activities:

               

Changes in operating assets and liabilities:

               

Decrease in prepaid expenses and other current assets

    3,281       137  

Increase in accounts payable and accrued expenses

    21,249       17,773  

Decrease in accounts payable and accrued expenses due to related parties

    21       (163

)

                 

Net cash used in operating activities

    (191,579

)

    (55,522

)

                 

Net decrease in cash and cash equivalents

    (191,579

)

    (55,522

)

                 

Cash and cash equivalents at beginning of period

    490,190       382,452  

Cash and cash equivalents at end of period

  $ 298,611     $ 326,930  
                 
                 

Supplemental disclosures of cash flow information:

               
                 

Cash paid during the period for interest

  $ -     $ -  

Cash paid during the period for income taxes

  $ -     $ -  

 

SEE ACCOMPANYING NOTES

 

 

OCULUS VISIONTECH INC. AND SUBSIDIARY

 

NOTES TO CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2021 and 2020 

(Stated in US Dollars)

(Unaudited)

 

 

1.

BASIS OF PRESENTATION AND BUSINESS

 

These unaudited condensed interim consolidated financial statements should be read in conjunction with the annual financial statements for Oculus VisionTech Inc. (“Oculus” or the “Company”) most recently completed fiscal year ended December 31, 2020. These unaudited condensed interim consolidated financial statements do not include all disclosures required in annual financial statements, but rather are prepared in accordance with recommendations for interim financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). These unaudited condensed interim consolidated financial statements have been prepared using the same accounting policies and methods as those used by the Company in the annual audited financial statements for the year ended December 31, 2020, except when disclosed below.

 

The accompanying condensed interim consolidated financial statements include the accounts of Oculus and its wholly-owned subsidiaries, OCL Technologies Corp. (from the date of acquisition, Note 6). All intercompany balances and transactions have been eliminated upon consolidation. In the opinion of the management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included. The results for the interim periods are not necessarily indicative of the results that may be attained for an entire year or any future periods. For further information, refer to the Financial Statements and footnotes thereto in the Company’s annual report on Form 10-K for the fiscal year ended December 31, 2020.

 

Oculus VisionTech, Inc. (the "Company") is a designer of digital watermarking services and solutions. At March 31, 2021 and fiscal 2020, substantially all of the Company's assets and substantially all its operations are located and conducted in the United States and Canada.

 

 

2.

GOING CONCERN

 

The accompanying condensed interim consolidated financial statements have been prepared assuming the Company will continue as a going concern.  As shown in the financial statements, the Company has incurred a loss of $393,620 for the three month period ended March 31, 2021 and, in addition the Company incurred losses of $2,772,484 and $192,865 for the year ended December 31, 2020 and 2019. As of March 31, 2021, the Company had an accumulated deficit of $44,552,800 and a working capital of $112,075. These conditions raise doubt about the Company’s ability to continue as a going concern.  The Company’s ability to continue as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations as they come due which management believes it will be able to do.  To date, the Company has funded operations primarily through the issuance of common stock and warrants to outside investors and the Company’s management.  The Company believes that its operations will generate additional funds and that additional funding from outside investors and the Company’s management will continue to be available to the Company when needed.  The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary in the event the Company cannot continue as a going concern.

 

 

3.

PREPAID EXPENSES AND OTHER CURRENT ASSETS

 

Prepaid expenses and other current assets consist of the following:

 

   

March 31,

2021

   

December 31,

2020

 
                 

Prepaid expenses

  $ 1,000     $ 1,030  

Tax Receivable – Canadian GST

    1,801       5,052  
    $ 2,801     $ 6,082  

 

 

 

4.

ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

Accounts payable and accrued expenses consist of the following:

 

   

March 31,

2021

   

December 31,

2020

 
                 

Accounts payable

  $ 53,578     $ 16,670  

Accrued fees and expenses

    -       15,659  
    $ 53,578     $ 32,329  

 

Accounts payable and accrued expenses – related parties consist of accounts payable for research and development, advances and accrued interest on related party debt.

 

 

5.

ACQUISITION OF OCL TECHNOLOGIES CORP. 

 

During the year ended December 31, 2020, the Company acquired a 100% interest in OCL Technologies Corp. (“OCL”) by issuing 12,500,000 shares with a fair value of $1,380,427 and contingent consideration consisting of 12,500,000 non-transferable warrants with a fair value of $414,128. The transaction does not meet the definition of a business as defined in ASC 805-10. As a result, the acquisition of OCL has been accounted for as an asset acquisition, whereby all of the assets acquired and liabilities assumed are assigned a carrying amount based on their relative fair values. Upon closing of the transaction, OCL became a subsidiary of the Company. The net assets acquired pursuant to the acquisition are as follows:

 

 

Purchase Price

       
         

Issuance of 12,500,000 shares

  $ 1,380,427  

Contingent consideration – warrants

    414,128  

Transaction costs

    54,532  
         

Total Purchase Price

  $ 1,849,087  

 

Contingent consideration consists of 12,500,000 non-transferable warrants that are exercisable into 12,500,000 common shares if certain criteria are met at an exercise price of $0.001 for a period of five years from the date of issuance expiry June 4, 2025. No share purchase warrants are exercisable until specific performance criteria have been met. Such criteria being 1) revenue sales projections per OCL’s 5 year proformas, or 2) listing on a major US exchange, or 3) change of control. The Company has estimated the fair value of the contingent consideration to be $414,128.

 

 

Purchase Price Allocation

       
         

Cash

  $ 114,169  

Accounts payable and due from related party

    (232,021 )

Intangible asset

    1,966,939  
         

Total Purchase Price

  $ 1,849,087  

 

During the year ended December 31, 2020, the Company impaired the intangible asset resulting an expense on the consolidated statement of operations of $1,966,939.

 

 

 

6.

COMMON STOCK 

 

The Company has one class of no par value common stock with 500,000,000 authorized shares 86,522,569 outstanding on March 31, 2021 and December 31, 2020, respectively.

 

On June 5, 2020, the Company issued 12,500,000 shares at a value of $0.15 CND per share pursuant to the acquisition of OCL Technologies Corp.

 

On June 5, 2020, the Company issued 7,000,001 shares to investors, including 1,766,667 common shares to a consultant and directors at $0.15 CND per share.

 

 

7.

STOCK OPTIONS  

 

During the period ended March 31, 2021 and year ended December 31, 2020, the Company adopted a Rolling Stock Option Plan. Up to 10% of the Company’s issued and outstanding common shares may be reserved for granting of stock options.

 

During the period ended March 31, 2021, the Company:

 

i) granted 500,000 stock options to consultants, exercisable into 500,000 shares at an exercise price of $1.20CND and an expiry date of January 29, 2024. The options have a fair value of $424,300CND, calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of 125%; (ii) Term of 3 years; (iii) Discount rate of 0.14%; (iv) Dividend rate of Nil; and (v) market stock price of $1.18. The options vest 20% every 6 months starting July 29, 2021. During the period ended March 31, 2021, the Company recorded $65,035CND ($51,351US) of stock-based compensation relating to the vesting period.

 

During the year ended December 31, 2020, the Company:

 

i) granted 3,600,000 stock options to consultants, directors and officers exercisable into 3,600,000 shares at an exercise price of $0.35CND and an expiry date of July 21, 2023. The options have a fair value of $909,900CND, calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of 125%; (ii) Term of 3 years; (iii) Discount rate of 0.27%; (iv) Dividend rate of Nil; and (v) market stock price of $0.35. The options vest 20% every 6 months starting January 21, 2020. During the year ended December 31, 2020, the Company recorded $369,597CND ($283,307US) of stock-based compensation relating to the vesting period. During the period ended March 31, 2021, the Company recorded $135,829CND ($107,249US) of stock-based compensation relating to the vesting period.

 

ii) granted 250,000 stock options to consultants, directors and officers exercisable into 250,000 shares at an exercise price of $0.45CND and an expiry date of December 21, 2023. The options have a fair value of $75,800CND, calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of 125%; (ii) Term of 3 years; (iii) Discount rate of 0.02%; (iv) Dividend rate of Nil; and (v) market stock price of $0.425. The options vest 20% every 6 months starting June 21, 2021. During the year ended December 31, 2020, the Company recorded $1,899CND ($1,486US) of stock-based compensation relating to the vesting period. During the period ended March 31, 2021, the Company recorded $23,925CND ($18,890US) of stock-based compensation relating to the vesting period.

 

 

8.

COVID-19  

 

In early 2020, a coronavirus that causes COVID-19 emerged globally, which is currently affecting the global economies and has a resulting effect on the Company.  Therefore, while the Company expects this matter to negatively impact the Company's financial condition, results of operations, or cash flows, the extent of the financial impact and duration cannot be reasonably estimated at this time.

 

 

9.

SUBSEQUENT EVENT  

 

Subsequent to March 31, 2021, the Company closed a non-brokered private placement financing of 4,900,000 units of the Company at a price of CDN$0.80 per unit for gross proceeds of CDN$3,920,000. Each unit consisted of one common share of the Company and one common share purchase warrant, with each warrant entitling the holder to acquire one additional common share of the Company at an exercise price of CDN $1.00 for a period of 24 months from the date of closing. The expiry date of the warrants may be accelerated at the Company’s discretion if, the closing price of the Shares on the TSX Venture Exchange is equal to or greater than CDN $2.50 for a minimum of ten consecutive trading days and a notice of acceleration is provided in accordance with the terms of the warrant.

 

 

 

Item 2.

Managements Discussion and Analysis of Financial Condition and Results of Operations.

 

FORWARD-LOOKING STATEMENTS AND SUPPLEMENTARY DATA

 

The following discussion should be read in conjunction with our condensed interim financial statements and other financial information appearing elsewhere in this quarterly report. In addition to historical information, the following discussion and other parts of this quarterly report contain forward-looking statements under applicable securities laws. You can identify these statements by forward-looking words such as “plan”, “may”, “will”, “expect”, “intend”, “anticipate”, believe”, “estimate” and “continue” or similar words. Forward-looking statements are statements that are not historical facts, and include, but are not limited to, statements regarding our products and services, including our digital watermarking technology and Cloud-based document protection system, our data privacy and data protection services and solutions, our technology, our cash needs, including our ability to fund our future capital expenditures and working capital requirements, and our expectations regarding competition and growth in our sector, are forward looking statements, the future sources and availability of additional funding, and the effect of funding arrangements on projects and products. You should read statements that contain these words carefully because they discuss future expectations and plans, which contain projections of future results of operations or financial condition or state other forward-looking information. We believe that it is important to communicate future expectations to investors. However, there may be events in the future that we are not able to accurately predict or control. Accordingly, we do not undertake any obligation to update any forward-looking statements for any reason, even if new information becomes available or other events occur in the future, except as required by law.

 

The forward-looking statements included herein are based on current expectations that involve a number of risks and uncertainties set forth under “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020 and other periodic reports filed with the United States Securities and Exchange Commission (“SEC”). Accordingly, to the extent that this quarterly report contains forward-looking statements regarding the financial condition, operating results, business prospects or any other aspect of the Company, please be advised that the Company’s actual financial condition, operating results and business performance may differ materially from that projected or estimated by the Company in forward-looking statements.

 

OVERVIEW OF THE COMPANY

 

Oculus VisionTech Inc. (OVTZ) is a Canadian-based development-stage technology company focused on cyber security, data privacy and data protection solutions for Enterprise business customers. Headquartered in Vancouver, British Columbia, Canada, the company was originally founded by image processing experts and is operated by experienced leadership. Currently, OVTZ is expanding and investing in a suite of new data protection and data privacy security products that will revolutionize CCPA, GDPR, LGPD and other data privacy legislation compliance for both data subjects and data controllers worldwide. Our mission is innovation of viable software tools that enable intelligent automated solutions for public cloud customer services and needs specific to data privacy and data protection for individuals, organizations and their customers worldwide, through a vision of mutually trusted data compliance.

 

Our Forget-Me-YesTM data privacy product is a Software-as-a-Service (SaaS) platform developed to specifically address the global ‘Right-to-be-Forgotten’ (RtbF) and Right-of-Erase (RoE) legal components of Brazil’s LGPD, Europe’s GDPR, California Consumer Privacy Act (CCPA), Nevada SB220, and Washington Privacy Act (WPA) regulatory compliance. Additional new data protection software tools are being developed to address public cloud data governance compliance globally. Our Cloud Document Protection System (Cloud-DPS) technology leverages our digital watermarking technology enabling OVTZ to offer a SaaS-based document management platform for tamper-proof document authentication and protection. Historically, we have used our digital watermarking technology for streaming video content distribution based on embedded digital watermarking, as well as video-on-demand (VOD) systems, services and source-to-destination digital media delivery solutions that allow live or recorded digitized and compressed video to be transmitted through Internet, intranet, satellite or wireless connectivity.

 

We were incorporated on April 18, 1986, as "First Commercial Financial Group Inc." in the Province of Alberta, Canada. In 1989, our name was changed to "Micron Metals Canada Corp.", which purchased 100% of the outstanding shares of USA Video Inc., a Texas corporation, in order to focus on the digital media business. In 1995, we changed our name to "USA Video Interactive Corp." and continued out of the Province of Alberta into the State of Wyoming. At a shareholders meeting held on December 30, 2011, a resolution was passed to change our name to "Oculus VisionTech Inc." and to alter our share capital by way of a reverse stock split (share consolidation) on the basis of fifteen old common shares for one new common share. On January 25, 2012, we changed our name to "Oculus VisionTech Inc." In June 2020, OVTZ acquired OCL Technologies Inc. (OCL), a Delaware corporation data privacy software development startup based in San Diego, California. As a 100% wholly-owned subsidiary of OVTZ and to better align with customer and market focus, OCL has completed a corporate name change to ComplyTrustTM Inc. (CTI) on January 21, 2021. All OCL references throughout this document are synonymous with the new name change, CTI.

 

Our executive and corporate headquarter offices are located at Suite 507, 837 West Hastings Street, Vancouver, British Columbia, Canada, V6C 3N6. Our telephone number is 1-800-684-0183 and our facsimile number is 604-685-5777. Our email address is contact@ovtz.com and our website is www.ovtz.com. Our common shares are listed for trading on the TSX Venture Exchange (TSX.V – OVT, OTCQB – OVTZ, FSE – USF1). 13

 

 

BUSINESS OBJECTIVES:

 

In this age of digital transformation, data monetization, IoT, and massive data migration to converged hyperscale, geo-disbursed Cloud infrastructure and workloads, data protection and data privacy have taken center stage. GDPR, LGPD, CCPA, and many other new international (China, India) and upcoming US data privacy regulations enable individuals and organizations the right to access and request deletion of all personal information for a given data subject. In our ever increasing Everything-as-a-Service world, OVTZ recognizes the need for global cloud-native data privacy and data protection solutions that are multi-cloud platform-ready and can augment both existing legacy and newer agile-driven architectures. OVTZ is building modular microservices-based software solutions and services for both hybrid on-premise and multi-cloud data management that incorporate automated malware, privacy and ransomware scanning, reporting and visualization.

 

Our new Forget-Me-YesTM (FMY) Software-as-a-Service (Saas) data privacy solution is a highly-secure, Zero-Knowledge platform providing a single-source capability of continuous ‘right-to-be-forgotten’ (RtbF) and ‘right-of-erase’ (RoE) privacy compliance by incorporating automated policy-driven re-query services that guarantees a Data Subject’s requested RtbF/RoE data remains ‘forgotten’ over the life of their FMY subscription. FMY incorporates hybrid polymorphic encryption technology that ensures all User Interface, data-in-transit and data-at-rest remain secure and can only be accessed by the subscriber. With a cloud-native architecture, the FMY functionality can be utilized as either a complete turnkey SaaS subscription platform, or individually licensed for seamless integration with existing 3rd. party applications and data privacy platforms.

 

Our new ComplyTrustTM Software-as-a-Service Suite (CTSS) is a set of software tools specifically designed to address cloud-native data management and regulatory compliant data governance. CTSS will help to remove enterprise organizational barriers and blockers to further enable successful cloud migration and deployment that benefit the cloud infrastructure providers, enterprise organizations, and users collectively. CTSS helps to automate and visualize cloud compliance reporting across accounts, regions and services based on a variety of user-definable and data driven metrics.

 

OVTZ had recognized that cloud-based, digital document security/protection products were a potentially viable businessopportunity for the Company that allowed us to apply our proprietary real-time digital video watermarking technology, originally developed for studios and networks in the entertainment industry, to the digital document security/protection market. Cloud-DPS secures and protects digital documents (including text documents, photos, blueprints, etc.) from any modification, and/or attempted forgery by imperceptibly watermarking documents, using real-time image processing and watermarking algorithms, embedded into a secured/protected copy of a document. This authentication and verification process ensures the integrity of the original digital document.

 

Our near-term business objectives for the above:

 

1.

Patent and license new technology developed within the corporate research and development program;

 

2.

Demonstrate proof of concept on selected commercial projects with our C-DPS – Cloud Document Protection System, Forget-Me-YesTM (FMY) data privacy Software-as-a-Service platform and ComplyTrustTM SaaS Suite (CTSS), gain industry recognition for the architectural and business differentiators of company’s product’s C-DPS authentication/tamper-proof functionality, FMY data privacy and CTSS tools, and generate sales and support revenues in FY21.

 

CRITICAL ACCOUNTING POLICIES (AND ESTIMATES)

 

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States.  The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities.  On an ongoing basis, we evaluate these estimates, including those related to customer programs and incentives, bad debts, inventories, investments, intangible assets, income taxes, warranty obligations, impairment or disposal of long-lived assets, contingencies and litigation.  We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources.  Actual results may differ from these estimates under different assumptions or conditions.

 

We have identified the policies below as critical to our business operations and to the understanding of our financial results. The impact and any associated risks related to these policies on our business operations is discussed throughout management’s discussion and analysis of financial condition and results of operations where such policies affect our reported and expected financial results:

 

 

Revenue recognition;

 

 

 

Impairment or disposal of long-lived assets;

 

Deferred taxes;

 

Accounting for stock-based compensation; and

 

Commitments and contingencies.

 

Revenue Recognition.  In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (Topic 606) ("ASC 606"). This guidance outlines a single, comprehensive model for accounting for revenue from contracts with customers to depict the transfer of control over a product to a customer. The guidance's core principle is that the Company will recognize revenue when it transfers control over promised goods or services to customers in an amount that reflects consideration to which the Company expects to be entitled in exchange for those goods or services.

 

Under ASC 606, a performance obligation is a promise in a contract with a customer to transfer a distinct good or service to a customer. The Company's contracts with customers typically contain a single performance obligation. A contract's transaction price is allocated to its distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. If there are multiple performance obligations within a contract, the Company allocates the transaction price to each performance obligation based on their relative standalone selling prices. Sales are recorded net of sales returns, discounts and allowances.

 

Impairment or Disposal of Long-Lived Assets.  Long-lived assets are reviewed in accordance with ASC Topic 360-10-05.  Impairment or disposal of long-lived assets losses are recognized in the period the impairment or disposal occurs.  

 

Deferred Taxes.  We record a valuation allowance to reduce deferred tax assets when it is more likely than not that some portion of the amount may not be realized.  

 

Accounting for Stock-Based Compensation.  Under ASC Topic 718, Stock Compensation (formerly referred to as SFAS No. 123(R)), the Company estimates the fair value of stock options granted using the Black-Scholes option pricing model. The fair value for awards that are expected to vest is then amortized on a straight-line basis over the requisite service period of the award, which is generally the option vesting term. The amount of expense attributed is based on estimated forfeiture rate, which is updated based on actual forfeitures as appropriate. This option pricing model requires the input of highly subjective assumptions, including the expected volatility of the Company’s common stock, pre-vesting forfeiture rate and an option’s expected life. The financial statements include amounts that are based on the Company’s best estimates and judgments.

 

Commitments and Contingencies.  We account for commitments and contingencies in accordance with ASC Topic 450 Contingencies (formerly referred to as financial accounting standards board Statement No. 5, Accounting for Contingencies). We record a liability for commitments and contingencies when the amount is both probable and reasonably estimable.

 

RESULTS OF OPERATIONS

 

Sales

 

Sales for the three month period ended March 31, 2021 and 2020 were $-0-

 

Cost of Sales

 

The cost of sales for the three months ended March 31, 2021 and 2020 were $-0-.

 

 

Selling, General and Administrative Expenses

 

Selling, general and administrative expenses, consisting of product marketing expenses, consulting fees, office, professional fees and other expenses to execute our business plan and for our day-to-day operations, increased in the period ended March 31, 2021.  We continue to develop and market C-DPS – Cloud Document Protection System and the “Right-to-be-Forgotten” and “Right-to-Erase” platform. Administrative expenses have decreased/increased moderately as a result of insignificant fluctuations in general costs.

 

Selling, general and administrative expenses for the period ended March 31, 2021 increased to $83,406 from $71,788 for the period ended March 31, 2020. This included professional expenses for the year ended December 31, 2020 which increased to $22,446 from $20,074. for the comparable period. We incurred increased costs in 2021 due to post acquisition legal and accounting costs.

 

Research and development for the period ended March 31, 2021 increased to $132,724 from $1,577 for the comparable period. This was a result of the Company’s acquisition of CTI and the research that they conduct.

 

We have arranged for additional staff and consultants to engage in marketing activities in an effort to identify and assess appropriate market segments, develop business arrangements with prospective partners, create awareness of new products and services, and communicate to the industry and potential customers. Other components of selling, general and administrative expenses did not change significantly.

 

Research and Development

 

Research and development costs for the three months ended March 31, 2021, increased to $132,724 from $1,577 for the comparable period. We incurred increased costs in 2021 due to management’s decision to develop C-DPS – Cloud Document Protection System as well as the development of our subsidiary’s zero trust data privacy platform. (“Right-to-be-Forgotten” and “Right-to-Erase”).

 

Net Losses

 

To date, we have not achieved profitability and expect to incur substantial losses for the foreseeable future. Our net loss for the three months ended March 31, 2021 was $393,620, compared with a net loss of $73,269 for the comparative period.

 

Liquidity and Capital Resources

 

At March 31, 2021, our cash position was $298,611, compared to $490,190 at December 31, 2020. We had a working capital of $112,075 and an accumulated deficit of $44,552,800 at March 31, 2021.

 

Subsequent to March 31, 2021, the Company closed a non-brokered private placement financing of 4,900,000 units of the Company at a price of CDN$0.80 per unit for gross proceeds of CDN$3,920,000. Each unit consisted of one common share of the Company and one common share purchase warrant, with each warrant entitling the holder to acquire one additional common share of the Company at an exercise price of CDN $1.00 for a period of 24 months from the date of closing. The expiry date of the warrants may be accelerated at the Company’s discretion if, the closing price of the Shares on the TSX Venture Exchange is equal to or greater than CDN $2.50 for a minimum of ten consecutive trading days and a notice of acceleration is provided in accordance with the terms of the warrant.

 

We have historically satisfied our capital needs primarily by issuing equity securities to our officers, directors, employees and a small group of investors, and from short-term bridge loans from members of management.

 

OFF-BALANCE SHEET ARRANGEMENTS

 

As of March 31, 2021 we have no off-balance sheet arrangements.

 

 

Item 3.         Quantitative and Qualitative Disclosures About Market Risk.

 

Oculus is a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and is not required to provide information required under this Item.

 

Item 4.         Controls and Procedures.

 

We maintain “disclosure controls and procedures”, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, that are designed to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer, who is our principal executive officer, and Chief Financial Officer, who is our principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating our disclosure controls and procedures, management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Additionally, in designing disclosure controls and procedures, our management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible disclosure controls and procedures.

 

As of March 31, 2021, we carried out an evaluation, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective in ensuring that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in the our internal control over financial reporting for the quarterly period ended March 31, 2021, identified in connection with the evaluation required by paragraph (d) of Rule 13a-15 or Rule 15d-15, that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

 

PART II - OTHER INFORMATION

 

Item 1.

Legal Proceedings.

 

From time to time, we may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or operating results.

 

Item 1A.

Risk Factors.

 

Oculus is a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and is not required to provide information required under this Item. A description of the risks associated with our business, financial condition, and results of operations is set forth in Part I, Item 1A, of our Annual Report on Form 10 -K for the fiscal year ended December 31, 2019 filed with the SEC on March 31, 2021. Those factors continue to be meaningful for your evaluation of Oculus and we urge you to review and consider the risk factors presented in such Form 10-K.

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds.

 

None.

 

Item 3.

Defaults Upon Senior Securities.

 

None.

 

Item 4.

Mine Safety Disclosures.

 

Not applicable.

 

Item 5.

Other Information.

 

None.

 

Item 6.

Exhibits.

 

The information required by this Item is set forth on the exhibit index which follows the signature page of this report.

 

Exhibit No.

 

Description

     

EX-31.1

 

Certification of CEO

     

EX-31.2

 

Certification of CFO

     

EX-32.1

 

SOX Certifiaction of CEO

     

EX-32.2

 

SOC Certification of CFO

 

101.INS

XBRL Instance Document

   

101.SCH

XBRL Taxonomy Extension Schema Document

   

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document

   

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document

   

101.LAB

XBRL Taxonomy Extension Label Linkbase Document

   

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

OCULUS VISIONTECH INC.

     

May 12, 2021

By:

/s/ Rowland Perkins

 
   

Rowland Perkins

   

President and Chief Executive Officer

   

(principal executive officer)

     
     

May 12, 2021

By:

/s/ Anton J. Drescher

 
   

Anton J. Drescher

   

Chief Financial Officer

   

(principal financial and accounting officer)

 

19
EX-31.1 2 ex_248745.htm EXHIBIT 31.1 ex_248745.htm

EXHIBIT 31.1

 

CERTIFICATION

 

I, Rowland Perkins, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Oculus VisionTech Inc..;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 12th, 2021

By:

/s/ Rowland Perkins

 
   

Rowland Perkins

 
   

Chief Executive Officer

(Principal Executive Officer)

 

 

 
EX-31.2 3 ex_248746.htm EXHIBIT 31.2 ex_248746.htm

EXHIBIT 31.2

 

CERTIFICATIONS

 

I, Anton J. Drescher, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Oculus VisionTech Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 12th, 2021

By:

/s/ Anton J. Drescher

   

Anton J. Drescher

   

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 
EX-32.1 4 ex_248747.htm EXHIBIT 32.1 ex_248747.htm

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Oculus VisionTech Inc. (the “Company”), for the period ended March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Rowland Perkins, Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

Date: May 12th, 2021

By:

/s/ Rowland Perkins

 
   

Rowland Perkins

 
   

Chief Executive Officer

(Principal Executive Officer)

 

 

 
EX-32.2 5 ex_248748.htm EXHIBIT 32.2 ex_248748.htm

EXHIBIT 32.2

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of Oculus VisionTech Inc. (the “Company”), for the period ended March 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Anton J. Drescher , Chief Financial Officer for the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

Date: May 12th, 2021

By:

/s/ Anton J. Drescher

 
   

Anton J. Drescher

 
   

Chief Financial Officer

(Principal Financial and Accounting Officer)

 

 

 
EX-101.INS 6 ovtz-20210331.xml XBRL INSTANCE DOCUMENT false --12-31 Q1 2021 2021-03-31 10-Q 0001107280 91422569 Yes false Non-accelerated Filer Yes OCULUS VISIONTECH INC. false true Common stock - no par value; Preferred stock - no par value ovtz 12500000 2.50 10 1 4900000 1 0.80 424300 909900 75800 0.1 0.1 112075 53578 32329 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">4.</div></div></div> </td> <td style="width: auto;"> <div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><div style="display: inline; font-weight: bold;">ACCOUNTS PAYABLE AND ACCRUED EXPENSES</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Accounts payable and accrued expenses consist of the following:</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">March 31,</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2021</div> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">December 31,</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2020</div> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 70%;"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Accounts payable</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">53,578</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">16,670</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Accrued fees and expenses</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">15,659</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">53,578</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">32,329</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&nbsp;</td> </tr> </table> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Accounts payable and accrued expenses &#x2013; related parties consist of accounts payable for research and development, advances and accrued interest on related party debt.</div></div> 53578 16670 15659 177490 177490 65035 51351 369597 283307 135829 107249 1899 1486 23925 18890 177490 301412 496272 54532 12500000 1 1849087 1380427 414128 114169 232021 1966939 1849087 298611 490190 490190 382452 298611 326930 -191579 -55522 0.001 1 1 12500000 12500000 0 0 500000000 500000000 86522569 86522569 86522569 86522569 44250747 44073257 393620 73365 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">March 31,</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2021</div> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">December 31,</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2020</div> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 70%;"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Prepaid expenses</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">1,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">1,030</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Tax Receivable &#x2013; Canadian GST</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,801</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">5,052</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">2,801</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">6,082</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">7.</div> </div></div> </td> <td style="width: auto;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><div style="display: inline; font-weight: bold;">STOCK OPTIONS</div>&nbsp;&nbsp;</div> </td> </tr> </table> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">During the period ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2021 </div>and year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020, </div>the Company adopted a Rolling Stock Option Plan. Up to <div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;">10%</div></div> of the Company's issued and outstanding common shares <div style="display: inline; font-style: italic; font: inherit;"> may </div>be reserved for granting of stock options.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">During the period ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2021, </div>the Company:</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">i) granted <div style="display: inline; font-style: italic; font: inherit;">500,000</div> stock options to consultants, exercisable into <div style="display: inline; font-style: italic; font: inherit;">500,000</div> shares at an exercise price of <div style="display: inline; font-style: italic; font: inherit;">$1.20CND</div> and an expiry date of <div style="display: inline; font-style: italic; font: inherit;"> January 29, 2024. </div>The options have a fair value of <div style="display: inline; font-style: italic; font: inherit;">$424,300CND,</div> calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of <div style="display: inline; font-style: italic; font: inherit;">125%;</div> (ii) Term of <div style="display: inline; font-style: italic; font: inherit;">3</div> years; (iii) Discount rate of <div style="display: inline; font-style: italic; font: inherit;">0.14%;</div> (iv) Dividend rate of <div style="display: inline; font-style: italic; font: inherit;">Nil;</div> and (v) market stock price of <div style="display: inline; font-style: italic; font: inherit;">$1.18.</div> The options vest <div style="display: inline; font-style: italic; font: inherit;">20%</div> every <div style="display: inline; font-style: italic; font: inherit;">6</div> months starting <div style="display: inline; font-style: italic; font: inherit;"> July 29, 2021. </div>During the period ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2021, </div>the Company recorded <div style="display: inline; font-style: italic; font: inherit;">$65,035CND</div> (<div style="display: inline; font-style: italic; font: inherit;">$51,351US</div>) of stock-based compensation relating to the vesting period.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">During the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020, </div>the Company:</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">i) granted <div style="display: inline; font-style: italic; font: inherit;">3,600,000</div> stock options to consultants, directors and officers exercisable into <div style="display: inline; font-style: italic; font: inherit;">3,600,000</div> shares at an exercise price of <div style="display: inline; font-style: italic; font: inherit;">$0.35CND</div> and an expiry date of <div style="display: inline; font-style: italic; font: inherit;"> July 21, 2023. </div>The options have a fair value of <div style="display: inline; font-style: italic; font: inherit;">$909,900CND,</div> calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of <div style="display: inline; font-style: italic; font: inherit;">125%;</div> (ii) Term of <div style="display: inline; font-style: italic; font: inherit;">3</div> years; (iii) Discount rate of <div style="display: inline; font-style: italic; font: inherit;">0.27%;</div> (iv) Dividend rate of <div style="display: inline; font-style: italic; font: inherit;">Nil;</div> and (v) market stock price of <div style="display: inline; font-style: italic; font: inherit;">$0.35.</div> The options vest <div style="display: inline; font-style: italic; font: inherit;">20%</div> every <div style="display: inline; font-style: italic; font: inherit;">6</div> months starting <div style="display: inline; font-style: italic; font: inherit;"> January 21, 2020. </div>During the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020, </div>the Company recorded <div style="display: inline; font-style: italic; font: inherit;">$369,597CND</div> (<div style="display: inline; font-style: italic; font: inherit;">$283,307US</div>) of stock-based compensation relating to the vesting period. During the period ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2021, </div>the Company recorded <div style="display: inline; font-style: italic; font: inherit;">$135,829CND</div> (<div style="display: inline; font-style: italic; font: inherit;">$107,249US</div>) of stock-based compensation relating to the vesting period.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">ii) granted <div style="display: inline; font-style: italic; font: inherit;">250,000</div> stock options to consultants, directors and officers exercisable into <div style="display: inline; font-style: italic; font: inherit;">250,000</div> shares at an exercise price of <div style="display: inline; font-style: italic; font: inherit;">$0.45CND</div> and an expiry date of <div style="display: inline; font-style: italic; font: inherit;"> December 21, 2023. </div>The options have a fair value of <div style="display: inline; font-style: italic; font: inherit;">$75,800CND,</div> calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of <div style="display: inline; font-style: italic; font: inherit;">125%;</div> (ii) Term of <div style="display: inline; font-style: italic; font: inherit;">3</div> years; (iii) Discount rate of <div style="display: inline; font-style: italic; font: inherit;">0.02%;</div> (iv) Dividend rate of <div style="display: inline; font-style: italic; font: inherit;">Nil;</div> and (v) market stock price of <div style="display: inline; font-style: italic; font: inherit;">$0.425.</div> The options vest <div style="display: inline; font-style: italic; font: inherit;">20%</div> every <div style="display: inline; font-style: italic; font: inherit;">6</div> months starting <div style="display: inline; font-style: italic; font: inherit;"> June 21, 2021. </div>During the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020, </div>the Company recorded <div style="display: inline; font-style: italic; font: inherit;">$1,899CND</div> (<div style="display: inline; font-style: italic; font: inherit;">$1,486US</div>) of stock-based compensation relating to the vesting period. During the period ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2021, </div>the Company recorded <div style="display: inline; font-style: italic; font: inherit;">$23,925CND</div> (<div style="display: inline; font-style: italic; font: inherit;">$18,890US</div>) of stock-based compensation relating to the vesting period.</div></div> 135759 135738 0 0 1966939 1801 5052 21249 17773 21 -163 -3281 -137 96 301412 496272 189337 168067 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">5.</div> </div></div> </td> <td style="width: auto;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><div style="display: inline; font-weight: bold;">ACQUISITION OF OCL TECHNOLOGIES CORP.</div>&nbsp;</div> </td> </tr> </table> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">During the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020, </div>the Company acquired a <div style="display: inline; font-style: italic; font: inherit;">100%</div> interest in OCL Technologies Corp. (&#x201c;OCL&#x201d;) by issuing <div style="display: inline; font-style: italic; font: inherit;">12,500,000</div> shares with a fair value of <div style="display: inline; font-style: italic; font: inherit;">$1,380,427</div> and contingent consideration consisting of <div style="display: inline; font-style: italic; font: inherit;">12,500,000</div> non-transferable warrants with a fair value of <div style="display: inline; font-style: italic; font: inherit;">$414,128.</div> The transaction does <div style="display: inline; font-style: italic; font: inherit;">not</div> meet the definition of a business as defined in ASC <div style="display: inline; font-style: italic; font: inherit;">805</div>-<div style="display: inline; font-style: italic; font: inherit;">10.</div> As a result, the acquisition of OCL has been accounted for as an asset acquisition, whereby all of the assets acquired and liabilities assumed are assigned a carrying amount based on their relative fair values. Upon closing of the transaction, OCL became a subsidiary of the Company. The net assets acquired pursuant to the acquisition are as follows:</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;text-indent:9pt;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 83%; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Purchase Price</div> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Issuance of 12,500,000 shares</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">1,380,427</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Contingent consideration &#x2013; warrants</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">414,128</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Transaction costs</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 14%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">54,532</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Total Purchase Price</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,849,087</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&nbsp;</td> </tr> </table> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Contingent consideration consists of <div style="display: inline; font-style: italic; font: inherit;">12,500,000</div> non-transferable warrants that are exercisable into <div style="display: inline; font-style: italic; font: inherit;">12,500,000</div> common shares if certain criteria are met at an exercise price of <div style="display: inline; font-style: italic; font: inherit;">$0.001</div> for a period of <div style="display: inline; font-style: italic; font: inherit;">five</div> years from the date of issuance expiry <div style="display: inline; font-style: italic; font: inherit;"> June 4, 2025. </div><div style="display: inline; font-style: italic; font: inherit;">No</div> share purchase warrants are exercisable until specific performance criteria have been met. Such criteria being <div style="display: inline; font-style: italic; font: inherit;">1</div>) revenue sales projections per OCL's <div style="display: inline; font-style: italic; font: inherit;">5</div> year proformas, or <div style="display: inline; font-style: italic; font: inherit;">2</div>) listing on a major US exchange, or <div style="display: inline; font-style: italic; font: inherit;">3</div>) change of control. The Company has estimated the fair value of the contingent consideration to be <div style="display: inline; font-style: italic; font: inherit;">$414,128.</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 83%; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Purchase Price Allocation</div> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Cash</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">114,169</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Accounts payable and due from related party</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">(232,021</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Intangible asset</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 14%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">1,966,939</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Total Purchase Price</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,849,087</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&nbsp;</td> </tr> </table> </div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">During the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020, </div>the Company impaired the intangible asset resulting an expense on the consolidated statement of operations of <div style="display: inline; font-style: italic; font: inherit;">$1,966,939.</div></div></div> -191579 -55522 -393620 -2772484 -192865 -73269 -73269 -393620 96 -393620 -73365 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">1.</div> </div></div> </td> <td style="width: auto;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><div style="display: inline; font-weight: bold;">BASIS OF PRESENTATION AND BUSINESS</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">These unaudited condensed interim consolidated financial statements should be read in conjunction with the annual financial statements for Oculus VisionTech Inc. (&#x201c;Oculus&#x201d; or the &#x201c;Company&#x201d;) most recently completed fiscal year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020. </div>These unaudited condensed interim consolidated financial statements do <div style="display: inline; font-style: italic; font: inherit;">not</div> include all disclosures required in annual financial statements, but rather are prepared in accordance with recommendations for interim financial statements in conformity with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;). These unaudited condensed interim consolidated financial statements have been prepared using the same accounting policies and methods as those used by the Company in the annual audited financial statements for the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020, </div>except when disclosed below.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The accompanying condensed interim consolidated financial statements include the accounts of Oculus and its wholly-owned subsidiaries, OCL Technologies Corp. (from the date of acquisition, Note <div style="display: inline; font-style: italic; font: inherit;">6</div>). All intercompany balances and transactions have been eliminated upon consolidation. In the opinion of the management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included. The results for the interim periods are <div style="display: inline; font-style: italic; font: inherit;">not</div> necessarily indicative of the results that <div style="display: inline; font-style: italic; font: inherit;"> may </div>be attained for an entire year or any future periods. For further information, refer to the Financial Statements and footnotes thereto in the Company's annual report on Form <div style="display: inline; font-style: italic; font: inherit;">10</div>-K for the fiscal year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020.</div></div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Oculus VisionTech, Inc. (the "<div style="display: inline; font-style: italic;">Company</div>") is a designer of digital watermarking services and solutions. At <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2021 </div>and fiscal <div style="display: inline; font-style: italic; font: inherit;">2020,</div> substantially all of the Company's assets and substantially all its operations are located and conducted in the United States and Canada.</div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">3.</div></div></div> </td> <td style="width: auto;"> <div style=" margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><div style="display: inline; font-weight: bold;">PREPAID EXPENSES AND OTHER CURRENT ASSETS</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Prepaid expenses and other current assets consist of the following:</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">March 31,</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2021</div> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">December 31,</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2020</div> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 70%;"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Prepaid expenses</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">1,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">1,030</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Tax Receivable &#x2013; Canadian GST</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,801</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">5,052</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">2,801</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">6,082</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&nbsp;</td> </tr> </table> </div></div> 0 0 250000000 250000000 0 0 2801 6082 1000 1030 3920000 132724 1577 -44552800 -44159180 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">March 31,</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2021</div> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td colspan="2" style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">December 31,</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">2020</div> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 70%;"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Accounts payable</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">53,578</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">16,670</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Accrued fees and expenses</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">15,659</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">53,578</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">32,329</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 83%; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Purchase Price</div> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Issuance of 12,500,000 shares</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">1,380,427</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Contingent consideration &#x2013; warrants</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">414,128</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Transaction costs</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 14%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">54,532</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Total Purchase Price</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,849,087</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin-right: 10%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px; min-; min-width: 700px;"> <tr style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 83%; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Purchase Price Allocation</div> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="text-align: justify; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-top: 3px double black; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Cash</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">114,169</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Accounts payable and due from related party</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">(232,021</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">)</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Intangible asset</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);">&nbsp;</td> <td style="width: 14%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); text-align: right;"><div style="display: inline; font-style: italic; font: inherit;">1,966,939</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> <div style=" font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Total Purchase Price</div> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);">&nbsp;</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 14%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; text-align: right; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">1,849,087</div></td> <td nowrap="nowrap" style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">&nbsp;</td> </tr> </table></div> 83406 71788 177490 0.0014 0.0027 0.0002 1.18 0.35 0.425 0 0 0 1.25 1.25 1.25 500000 3600000 250000 1.20 0.35 0.45 500000 3600000 250000 0.2 0.2 0.2 P3Y P3Y P3Y 67022568 86522569 86522569 86522569 0.15 0.15 0.15 12500000 7000001 1766667 112075 328205 41634999 -41386696 248303 44073257 414128 -41459965 175034 44073257 414128 -44159180 44250747 414128 -44552800 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">6.</div> </div></div> </td> <td style="width: auto;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><div style="display: inline; font-weight: bold;">COMMON STOCK</div>&nbsp;</div> </td> </tr> </table> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company has <div style="display: inline; font-style: italic; font: inherit;">one</div> class of <div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;">no</div></div> par value common stock with <div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;">500,000,000</div></div> authorized shares <div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;">86,522,569</div></div>&nbsp;outstanding on <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2021 </div>and <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020, </div>respectively.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On <div style="display: inline; font-style: italic; font: inherit;"> June 5, 2020, </div>the Company issued <div style="display: inline; font-style: italic; font: inherit;">12,500,000</div> shares at a value of <div style="display: inline; font-style: italic; font: inherit;">$0.15</div> CND per share pursuant to the acquisition of OCL Technologies Corp.</div> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On <div style="display: inline; font-style: italic; font: inherit;"> June 5, 2020, </div>the Company issued <div style="display: inline; font-style: italic; font: inherit;">7,000,001</div> shares to investors, including <div style="display: inline; font-style: italic; font: inherit;">1,766,667</div> common shares to a consultant and directors at <div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;">$0.15</div></div> CND per share.</div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">9.</div> </div></div> </td> <td style="width: auto;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><div style="display: inline; font-weight: bold;">SUBSEQUENT EVENT</div>&nbsp;&nbsp;</div> </td> </tr> </table> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Subsequent to <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2021, </div>the Company closed a non-brokered private placement financing of <div style="display: inline; font-style: italic; font: inherit;">4,900,000</div> units of the Company at a price of <div style="display: inline; font-style: italic; font: inherit;">CDN$0.80</div> per unit for gross proceeds of <div style="display: inline; font-style: italic; font: inherit;">CDN$3,920,000.</div> Each unit consisted of <div style="display: inline; font-style: italic; font: inherit;">one</div> common share of the Company and <div style="display: inline; font-style: italic; font: inherit;">one</div> common share purchase warrant, with each warrant entitling the holder to acquire <div style="display: inline; font-style: italic; font: inherit;">one</div> additional common share of the Company at an exercise price of CDN <div style="display: inline; font-style: italic; font: inherit;">$1.00</div> for a period of <div style="display: inline; font-style: italic; font: inherit;">24</div> months from the date of closing. The expiry date of the warrants <div style="display: inline; font-style: italic; font: inherit;"> may </div>be accelerated at the Company's discretion if, the closing price of the Shares on the TSX Venture Exchange is equal to or greater than CDN <div style="display: inline; font-style: italic; font: inherit;">$2.50</div> for a minimum of <div style="display: inline; font-style: italic; font: inherit;">ten</div> consecutive trading days and a notice of acceleration is provided in accordance with the terms of the warrant.</div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">2.</div> </div></div> </td> <td style="width: auto;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><div style="display: inline; font-weight: bold;">GOING CONCERN </div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The accompanying condensed interim consolidated financial statements have been prepared assuming the Company will continue as a going concern. &nbsp;As shown in the financial statements, the Company has incurred a loss of <div style="display: inline; font-style: italic; font: inherit;">$393,620</div> for the <div style="display: inline; font-style: italic; font: inherit;">three</div> month period ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2021 </div>and, in addition the Company incurred losses of <div style="display: inline; font-style: italic; font: inherit;">$2,772,484</div> and <div style="display: inline; font-style: italic; font: inherit;">$192,865</div> for the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020 </div>and <div style="display: inline; font-style: italic; font: inherit;">2019.</div> As of <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2021, </div>the Company had an accumulated deficit of <div style="display: inline; font-style: italic; font: inherit;">$44,552,800</div> and a working capital of <div style="display: inline; font-style: italic; font: inherit;">$112,075.</div> These conditions raise doubt about the Company's ability to continue as a going concern. &nbsp;The Company's ability to continue as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations as they come due which management believes it will be able to do. &nbsp;To date, the Company has funded operations primarily through the issuance of common stock and warrants to outside investors and the Company's management. &nbsp;The Company believes that its operations will generate additional funds and that additional funding from outside investors and the Company's management will continue to be available to the Company when needed. &nbsp;The financial statements do <div style="display: inline; font-style: italic; font: inherit;">not</div> include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary in the event the Company cannot continue as a going concern.</div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 36pt;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">8.</div> </div></div> </td> <td style="width: auto;"> <div style=" font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><div style="display: inline; font-weight: bold;">COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div></div>&nbsp;&nbsp;</div> </td> </tr> </table> <div style=" font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</div> <div style=" font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In early <div style="display: inline; font-style: italic; font: inherit;">2020,</div> a coronavirus that causes COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> emerged globally, which is currently affecting the global economies and has a resulting effect on the Company. &nbsp;Therefore, while the Company expects this matter to negatively impact the Company's financial condition, results of operations, or cash flows, the extent of the financial impact and duration cannot be reasonably estimated at this time.</div></div> 414128 414128 414128 414128 P5Y P2Y 86522569 67022568 xbrli:shares xbrli:pure iso4217:CAD xbrli:shares iso4217:USD iso4217:CAD iso4217:USD xbrli:shares 0001107280 2019-01-01 2019-12-31 0001107280 2020-01-01 2020-03-31 0001107280 ovtz:CommitmentToIssueSharesMember 2020-01-01 2020-03-31 0001107280 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001107280 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001107280 2020-01-01 2020-12-31 0001107280 ovtz:December2020Member us-gaap:EmployeeStockOptionMember ovtz:RollingStockOptionPlanMember 2020-01-01 2020-12-31 0001107280 ovtz:July2020Member us-gaap:EmployeeStockOptionMember ovtz:RollingStockOptionPlanMember 2020-01-01 2020-12-31 0001107280 ovtz:OCLTechnologiesCorpMember 2020-01-01 2020-12-31 0001107280 ovtz:OCLTechnologiesCorpMember ovtz:WarrantsIssuedInConnectionWithBusinessAcquisitionMember 2020-01-01 2020-12-31 0001107280 ovtz:EmployeeAndDirectorsMember 2020-06-05 2020-06-05 0001107280 ovtz:InvestorsMember 2020-06-05 2020-06-05 0001107280 ovtz:OCLTechnologiesCorpMember 2020-06-05 2020-06-05 0001107280 us-gaap:EmployeeStockOptionMember ovtz:RollingStockOptionPlanMember 2020-07-21 2020-07-21 0001107280 us-gaap:EmployeeStockOptionMember ovtz:RollingStockOptionPlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2020-07-21 2020-07-21 0001107280 ovtz:RollingStockOptionPlanMember 2020-07-21 2020-07-21 0001107280 us-gaap:EmployeeStockOptionMember ovtz:RollingStockOptionPlanMember 2020-12-21 2020-12-21 0001107280 us-gaap:EmployeeStockOptionMember ovtz:RollingStockOptionPlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2020-12-21 2020-12-21 0001107280 ovtz:RollingStockOptionPlanMember 2020-12-21 2020-12-21 0001107280 2021-01-01 2021-03-31 0001107280 ovtz:December2020Member us-gaap:EmployeeStockOptionMember ovtz:RollingStockOptionPlanMember 2021-01-01 2021-03-31 0001107280 ovtz:January2021Member us-gaap:EmployeeStockOptionMember ovtz:RollingStockOptionPlanMember 2021-01-01 2021-03-31 0001107280 ovtz:July2020Member us-gaap:EmployeeStockOptionMember ovtz:RollingStockOptionPlanMember 2021-01-01 2021-03-31 0001107280 ovtz:CommitmentToIssueSharesMember 2021-01-01 2021-03-31 0001107280 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001107280 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001107280 ovtz:Covid19Member 2021-01-01 2021-03-31 0001107280 us-gaap:EmployeeStockOptionMember ovtz:RollingStockOptionPlanMember 2021-01-29 2021-01-29 0001107280 us-gaap:EmployeeStockOptionMember ovtz:RollingStockOptionPlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2021-01-29 2021-01-29 0001107280 ovtz:RollingStockOptionPlanMember 2021-01-29 2021-01-29 0001107280 ovtz:WarrantsIssuedInConnectionWithPrivatePlacementMember 2021-04-01 2021-05-12 0001107280 us-gaap:PrivatePlacementMember 2021-04-01 2021-05-12 0001107280 2019-12-31 0001107280 ovtz:CommitmentToIssueSharesMember 2019-12-31 0001107280 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-12-31 0001107280 us-gaap:RetainedEarningsMember 2019-12-31 0001107280 2020-03-31 0001107280 ovtz:CommitmentToIssueSharesMember 2020-03-31 0001107280 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-03-31 0001107280 us-gaap:RetainedEarningsMember 2020-03-31 0001107280 ovtz:EmployeeAndDirectorsMember 2020-06-05 0001107280 ovtz:InvestorsMember 2020-06-05 0001107280 ovtz:OCLTechnologiesCorpMember 2020-06-05 0001107280 ovtz:RollingStockOptionPlanMember 2020-07-21 0001107280 ovtz:RollingStockOptionPlanMember 2020-12-21 0001107280 2020-12-31 0001107280 ovtz:OCLTechnologiesCorpMember 2020-12-31 0001107280 ovtz:OCLTechnologiesCorpMember ovtz:WarrantsIssuedInConnectionWithBusinessAcquisitionMember 2020-12-31 0001107280 ovtz:RollingStockOptionPlanMember 2020-12-31 0001107280 ovtz:CommitmentToIssueSharesMember 2020-12-31 0001107280 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-12-31 0001107280 us-gaap:RetainedEarningsMember 2020-12-31 0001107280 ovtz:RollingStockOptionPlanMember 2021-01-29 0001107280 2021-03-31 0001107280 ovtz:RollingStockOptionPlanMember 2021-03-31 0001107280 ovtz:CommitmentToIssueSharesMember 2021-03-31 0001107280 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2021-03-31 0001107280 us-gaap:RetainedEarningsMember 2021-03-31 0001107280 2021-05-12 0001107280 ovtz:WarrantsIssuedInConnectionWithPrivatePlacementMember 2021-05-12 0001107280 us-gaap:PrivatePlacementMember 2021-05-12 EX-101.SCH 7 ovtz-20210331.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Condensed Interim Consolidated Balance Sheets (Current Period Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Condensed Interim Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Consolidated Statements of Operations (Unaudited) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Consolidated Statements of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 1 - Basis of Presentation and Business link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 2 - Going Concern link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 3 - Prepaid Expenses and Other Current Assets link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 4 - Accounts Payable and Accrued Expenses link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 5 - Acquisition of OCL Technologies Corp. link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 6 - Common Stock link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 7 - Stock Options link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 8 - COVID-19 link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 9 - Subsequent Event link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 3 - Prepaid Expenses and Other Current Assets (Tables) link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 4 - Accounts Payable and Accrued Expenses (Tables) link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 5 - Acquisition of OCL Technologies Corp. (Tables) link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 2 - Going Concern (Details Textual) link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 3 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 4 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details) link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 5 - Acquisition of OCL Technologies Corp. (Details Textual) link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 5 - Acquisition of OCL Technologies Corp. - Purchase Price (Details) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 5 - Acquisition of OCL Technologies Corp. - Purchase Price (Details) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 5 - Acquisition of OCL Technologies Corp. - Purchase Price Allocation (Details) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 6 - Common Stock (Details Textual) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 7 - Stock Options (Details Textual) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 9 - Subsequent Event (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 8 ovtz-20210331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 ovtz-20210331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 ovtz-20210331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price (in CAD per share) Note To Financial Statement Details Textual Increase in accounts payable and accrued expenses us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Intangible asset Common Stock Including Additional Paid in Capital [Member] Note 3 - Prepaid Expenses and Other Current Assets Note 4 - Accounts Payable and Accrued Expenses Note 5 - Acquisition of OCL Technologies Corp. Note 3 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions Note 4 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details) Note 5 - Acquisition of OCL Technologies Corp. - Purchase Price (Details) Note 5 - Acquisition of OCL Technologies Corp. - Purchase Price (Details) (Parentheticals) Note 5 - Acquisition of OCL Technologies Corp. - Purchase Price Allocation (Details) Equity Components [Axis] Notes To Financial Statements Equity Component [Domain] Notes To Financial Statements [Abstract] Cash us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Add back non-cash share-based compensation us-gaap_LiabilitiesCurrent Total current liabilities Accounts payable and accrued expenses - related parties us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Year) Issuance of 12,500,000 shares Business Combination, Consideration Transferred, Equity Interests Issued and Issuable us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in shares) Total Purchase Price us-gaap_ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding (in shares) us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired Business Acquisition, Percentage of Voting Interests Acquired Decrease in accounts payable and accrued expenses due to related parties Cash and cash equivalents us-gaap_CashAndCashEquivalentsAtCarryingValue us-gaap_SharesIssued Balance (in shares) Balance (in shares) us-gaap_SharesIssuedPricePerShare Shares Issued, Price Per Share (in CAD per share) Stock-based compensation (Note 7) us-gaap_AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in CAD per share) Stockholders' Equity Note Disclosure [Text Block] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in shares) Amendment Flag Tax Receivable – Canadian GST Accounting Policies [Abstract] us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill), Total Common stock and additional paid-in capital - no par value; authorized 500,000,000 shares, issued and outstanding 86,522,569 and 86,522,569 Entity Interactive Data Current Common stock, shares authorized (in shares) Common Stock, Shares Authorized (in shares) Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding, Ending Balance (in shares) Accounts payable and accrued expenses Accounts Payable and Accrued Liabilities, Current, Total Common stock, shares issued (in shares) Title of 12(b) Security Common stock, no par value (in dollars per share) Common Stock, No Par Value (in dollars per share) Current Fiscal Year End Date us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Decrease in prepaid expenses and other current assets Document Fiscal Period Focus Document Fiscal Year Focus us-gaap_AccountsPayableCurrent Accounts payable Document Period End Date Entity Emerging Growth Company Document Type Preferred stock - no par value; authorized 250,000,000 shares, none issued Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Entity Small Business Preferred stock, shares issued (in shares) Entity Shell Company Cash paid during the period for interest us-gaap_PolicyTextBlockAbstract Accounting Policies Cash paid during the period for income taxes Prepaid expenses Preferred stock, no par value (in dollars per share) Document Information [Line Items] Document Information [Table] Preferred stock, shares outstanding (in shares) Entity Filer Category Unusual or Infrequent Item, or Both [Axis] Entity Current Reporting Status Accrued fees and expenses Unusual or Infrequent Item, or Both [Domain] Revenue Unusual or Infrequent Items, or Both, Disclosure [Text Block] Weighted average number of common shares outstanding – basic and diluted (in shares) July 2020 [Member] Represents July 2020. us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue Share-based compensation us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage December 2020 [Member] Represents December 2020. Net loss per share - basic and diluted (in dollars per share) Entity Central Index Key Entity Registrant Name Current Liabilities: Entity [Domain] Vesting [Axis] Legal Entity [Axis] Vesting [Domain] Statement [Table] Share-based Payment Arrangement, Tranche One [Member] Statement of Financial Position [Abstract] Supplemental disclosures of cash flow information: us-gaap_Assets Total Assets Accounts Payable and Accrued Liabilities Disclosure [Text Block] Plan Name [Axis] Interest income Plan Name [Domain] Business Acquisition [Axis] Other Assets Disclosure [Text Block] Business Acquisition, Acquiree [Domain] Cash flows from operating activities: COVID-19 [Member] Represents COVID-19. ovtz_WorkingCapitalDeficit Working Capital (Deficit) Represents the amount of difference between Current Assets and Current Liabilities. Statement of Cash Flows [Abstract] Commitment to issue shares Warrants and Rights Outstanding Statement [Line Items] Entity Common Stock, Shares Outstanding (in shares) Mergers, Acquisitions and Dispositions Disclosures [Text Block] Statement of Stockholders' Equity [Abstract] Income Statement [Abstract] Commitment to Issue Shares [Member] Represents commitment to issue shares. Share-based Payment Arrangement [Text Block] Transaction costs Stockholders' Equity: Trading Symbol Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares) us-gaap_NonoperatingIncomeExpense Nonoperating Income (Expense), Total Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Award Type [Domain] Award Date [Axis] Award Date [Domain] Net loss us-gaap_NetIncomeLoss Net Income (Loss) Attributable to Parent, Total Net loss Award Type [Axis] us-gaap_TableTextBlock Notes Tables us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period ASSETS Private Placement [Member] us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Net decrease in cash and cash equivalents Warrants Issued in Connection With Business Acquisition [Member] Represents warrants issued in connection with business acquisition. Commitments and Contingencies OCL Technologies Corp [Member] Represents OCL Technologies Corp. Sale of Stock [Axis] Sale of Stock [Domain] Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] us-gaap_OperatingIncomeLoss Loss from operations Share-based Payment Arrangement, Option [Member] us-gaap_NetCashProvidedByUsedInOperatingActivities Net cash used in operating activities Other income us-gaap_PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets ovtz_EquityOfferingPricePerUnitIssued Equity Offering, Price Per Unit Issued (in CAD per share) The price per unit issued in the equity offering. ovtz_EquityOfferingNumberOfCommonSharesPerUnit Equity Offering, Number of Common Shares Per Unit (in shares) The number of common shares per unit in the equity offering. Selling, general and administrative ovtz_EquityOfferingNumberOfWarrantsPerUnit Equity Offering, Number of Warrants Per Unit (in shares) The number of warrant per unit in the equity offering. ovtz_ClassOfWarrantOfRightStockPriceTrigger Class of Warrant of Right, Stock Price Trigger (in CAD per share) Price of the entity's common stock which would be required to be attained for the conversion of warrant or right to be accelerated Counterparty Name [Axis] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares) January 2021 [Member] Represents January 2021. Counterparty Name [Domain] Warrants Issued in Connection with Private Placement [Member] Represents the warrants issued in connection with the private placement. us-gaap_WarrantsAndRightsOutstandingTerm Warrants and Rights Outstanding, Term (Year) ovtz_EquityOfferingNumberOfUnitsIssued Equity Offering, Number of Units Issued (in shares) The number of units issued during the period in the equity offering. us-gaap_StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues (in shares) ovtz_ClassOfWarrantOrRightThresholdConsecutiveTradingDays Class of Warrant or Right, Threshold Consecutive Trading Days Threshold period of specified consecutive trading days within which common stock price to conversion price of warrant or right must exceed threshold percentage for specified number of trading days to trigger conversion feature. Schedule of Business Acquisitions, by Acquisition [Table Text Block] us-gaap_LiabilitiesAndStockholdersEquity Total Liabilities and Stockholders' Equity Shares issued (in shares) Amount of equity interests of the acquirer in shares, including instruments or interests issued or issuable in consideration for the business combination. Accumulated deficit Retained Earnings (Accumulated Deficit), Ending Balance Research and development us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet Total Purchase Price Investors [Member] Represents the investors of the company. Employee and Directors [Member] Represents the employee and directors of the company. Changes in operating assets and liabilities: us-gaap_StockholdersEquity Stockholders' equity Balance Balance ovtz_SharebasedCompensationArrangementPercentOfIssuedAndOutstandingCommonSharesReserved Share-based Compensation Arrangement, Percent of Issued and Outstanding Common Shares Reserved The percent of issued and outstanding common shares reserved in a share-based compensation. us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements Substantial Doubt about Going Concern [Text Block] us-gaap_CostsAndExpenses Total expenses Class of Stock [Axis] Rolling Stock Option Plan [Member] Related to the Rolling Stock Option Plan. us-gaap_ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity, Total Expenses: Subsequent Events [Text Block] us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable Accounts payable and due from related party Retained Earnings [Member] ovtz_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value Represents the fair value of options under the share-based compensation. EX-101.PRE 11 ovtz-20210331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT v3.21.1
Document And Entity Information - shares
3 Months Ended
Mar. 31, 2021
May 12, 2021
Document Information [Line Items]    
Entity Registrant Name OCULUS VISIONTECH INC.  
Entity Central Index Key 0001107280  
Trading Symbol ovtz  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Entity Current Reporting Status Yes  
Entity Emerging Growth Company false  
Entity Small Business true  
Entity Interactive Data Current Yes  
Entity Common Stock, Shares Outstanding (in shares)   91,422,569
Entity Shell Company false  
Document Type 10-Q  
Document Period End Date Mar. 31, 2021  
Document Fiscal Year Focus 2021  
Document Fiscal Period Focus Q1  
Amendment Flag false  
Title of 12(b) Security Common stock - no par value; Preferred stock - no par value  
XML 13 R2.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Interim Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
ASSETS    
Cash and cash equivalents $ 298,611 $ 490,190
Prepaid expenses and other current assets 2,801 6,082
Total Assets 301,412 496,272
Current Liabilities:    
Accounts payable and accrued expenses 53,578 32,329
Accounts payable and accrued expenses - related parties 135,759 135,738
Total current liabilities 189,337 168,067
Commitments and Contingencies
Stockholders' Equity:    
Preferred stock - no par value; authorized 250,000,000 shares, none issued
Common stock and additional paid-in capital - no par value; authorized 500,000,000 shares, issued and outstanding 86,522,569 and 86,522,569 44,250,747 44,073,257
Commitment to issue shares 414,128 414,128
Accumulated deficit (44,552,800) (44,159,180)
Stockholders' equity 112,075 328,205
Total Liabilities and Stockholders' Equity $ 301,412 $ 496,272
XML 14 R3.htm IDEA: XBRL DOCUMENT v3.21.1
Condensed Interim Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares
Mar. 31, 2021
Dec. 31, 2020
Preferred stock, no par value (in dollars per share) $ 0 $ 0
Preferred stock, shares outstanding (in shares) 250,000,000 250,000,000
Preferred stock, shares issued (in shares) 0 0
Common stock, no par value (in dollars per share) $ 0 $ 0
Common stock, shares authorized (in shares) 500,000,000 500,000,000
Common stock, shares issued (in shares) 86,522,569 86,522,569
Common stock, shares outstanding (in shares) 86,522,569 86,522,569
XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Operations (Unaudited) - USD ($)
$ / shares in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Revenue
Expenses:    
Research and development 132,724 1,577
Selling, general and administrative 83,406 71,788
Stock-based compensation (Note 7) 177,490
Total expenses 393,620 73,365
Loss from operations (393,620) (73,365)
Other income    
Interest income 96
Nonoperating Income (Expense), Total 96
Net loss $ (393,620) $ (73,269)
Net loss per share - basic and diluted (in dollars per share) $ 0 $ 0
Weighted average number of common shares outstanding – basic and diluted (in shares) 86,522,569 67,022,568
XML 16 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock Including Additional Paid in Capital [Member]
Commitment to Issue Shares [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2019 67,022,568      
Balance at Dec. 31, 2019 $ 41,634,999 $ (41,386,696) $ 248,303
Net loss (73,269) (73,269)
Balance (in shares) at Mar. 31, 2020 86,522,569      
Balance at Mar. 31, 2020 $ 44,073,257 414,128 (41,459,965) 175,034
Balance (in shares) at Dec. 31, 2019 67,022,568      
Balance at Dec. 31, 2019 $ 41,634,999 (41,386,696) 248,303
Net loss       (2,772,484)
Balance (in shares) at Dec. 31, 2020 86,522,569      
Balance at Dec. 31, 2020 $ 44,073,257 414,128 (44,159,180) 328,205
Net loss (393,620) (393,620)
Share-based compensation $ 177,490 177,490
Balance (in shares) at Mar. 31, 2021 86,522,569      
Balance at Mar. 31, 2021 $ 44,250,747 $ 414,128 $ (44,552,800) $ 112,075
XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Cash flows from operating activities:        
Net loss $ (393,620) $ (73,269) $ (2,772,484) $ (192,865)
Add back non-cash share-based compensation 177,490    
Changes in operating assets and liabilities:        
Decrease in prepaid expenses and other current assets 3,281 137    
Increase in accounts payable and accrued expenses 21,249 17,773    
Decrease in accounts payable and accrued expenses due to related parties 21 (163)    
Net cash used in operating activities (191,579) (55,522)    
Net decrease in cash and cash equivalents (191,579) (55,522)    
Cash and cash equivalents at beginning of period 490,190 382,452 382,452  
Cash and cash equivalents at end of period 298,611 326,930 $ 490,190 $ 382,452
Supplemental disclosures of cash flow information:        
Cash paid during the period for interest    
Cash paid during the period for income taxes    
XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Note 1 - Basis of Presentation and Business
3 Months Ended
Mar. 31, 2021
Notes to Financial Statements  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
1.
BASIS OF PRESENTATION AND BUSINESS
 
These unaudited condensed interim consolidated financial statements should be read in conjunction with the annual financial statements for Oculus VisionTech Inc. (“Oculus” or the “Company”) most recently completed fiscal year ended
December 31, 2020.
These unaudited condensed interim consolidated financial statements do
not
include all disclosures required in annual financial statements, but rather are prepared in accordance with recommendations for interim financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). These unaudited condensed interim consolidated financial statements have been prepared using the same accounting policies and methods as those used by the Company in the annual audited financial statements for the year ended
December 31, 2020,
except when disclosed below.
 
The accompanying condensed interim consolidated financial statements include the accounts of Oculus and its wholly-owned subsidiaries, OCL Technologies Corp. (from the date of acquisition, Note
6
). All intercompany balances and transactions have been eliminated upon consolidation. In the opinion of the management, all adjustments (consisting of normal recurring accruals) considered necessary for fair presentation have been included. The results for the interim periods are
not
necessarily indicative of the results that
may
be attained for an entire year or any future periods. For further information, refer to the Financial Statements and footnotes thereto in the Company's annual report on Form
10
-K for the fiscal year ended
December 31, 2020.
 
Oculus VisionTech, Inc. (the "
Company
") is a designer of digital watermarking services and solutions. At
March 31, 2021
and fiscal
2020,
substantially all of the Company's assets and substantially all its operations are located and conducted in the United States and Canada.
XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.1
Note 2 - Going Concern
3 Months Ended
Mar. 31, 2021
Notes to Financial Statements  
Substantial Doubt about Going Concern [Text Block]
2.
GOING CONCERN
 
The accompanying condensed interim consolidated financial statements have been prepared assuming the Company will continue as a going concern.  As shown in the financial statements, the Company has incurred a loss of
$393,620
for the
three
month period ended
March 31, 2021
and, in addition the Company incurred losses of
$2,772,484
and
$192,865
for the year ended
December 31, 2020
and
2019.
As of
March 31, 2021,
the Company had an accumulated deficit of
$44,552,800
and a working capital of
$112,075.
These conditions raise doubt about the Company's ability to continue as a going concern.  The Company's ability to continue as a going concern is dependent upon its ability to generate sufficient cash flow to meet its obligations as they come due which management believes it will be able to do.  To date, the Company has funded operations primarily through the issuance of common stock and warrants to outside investors and the Company's management.  The Company believes that its operations will generate additional funds and that additional funding from outside investors and the Company's management will continue to be available to the Company when needed.  The financial statements do
not
include any adjustments relating to the recoverability and classification of recorded assets, or the amounts and classifications of liabilities that might be necessary in the event the Company cannot continue as a going concern.
XML 20 R9.htm IDEA: XBRL DOCUMENT v3.21.1
Note 3 - Prepaid Expenses and Other Current Assets
3 Months Ended
Mar. 31, 2021
Notes to Financial Statements  
Other Assets Disclosure [Text Block]
3.
PREPAID EXPENSES AND OTHER CURRENT ASSETS
 
Prepaid expenses and other current assets consist of the following:
 
   
March 31,
2021
   
December 31,
2020
 
                 
Prepaid expenses
  $
1,000
    $
1,030
 
Tax Receivable – Canadian GST
   
1,801
     
5,052
 
    $
2,801
    $
6,082
 
XML 21 R10.htm IDEA: XBRL DOCUMENT v3.21.1
Note 4 - Accounts Payable and Accrued Expenses
3 Months Ended
Mar. 31, 2021
Notes to Financial Statements  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
4.
ACCOUNTS PAYABLE AND ACCRUED EXPENSES
 
Accounts payable and accrued expenses consist of the following:
 
   
March 31,
2021
   
December 31,
2020
 
                 
Accounts payable
  $
53,578
    $
16,670
 
Accrued fees and expenses
   
-
     
15,659
 
    $
53,578
    $
32,329
 
 
Accounts payable and accrued expenses – related parties consist of accounts payable for research and development, advances and accrued interest on related party debt.
XML 22 R11.htm IDEA: XBRL DOCUMENT v3.21.1
Note 5 - Acquisition of OCL Technologies Corp.
3 Months Ended
Mar. 31, 2021
Notes to Financial Statements  
Mergers, Acquisitions and Dispositions Disclosures [Text Block]
5.
ACQUISITION OF OCL TECHNOLOGIES CORP.
 
 
During the year ended
December 31, 2020,
the Company acquired a
100%
interest in OCL Technologies Corp. (“OCL”) by issuing
12,500,000
shares with a fair value of
$1,380,427
and contingent consideration consisting of
12,500,000
non-transferable warrants with a fair value of
$414,128.
The transaction does
not
meet the definition of a business as defined in ASC
805
-
10.
As a result, the acquisition of OCL has been accounted for as an asset acquisition, whereby all of the assets acquired and liabilities assumed are assigned a carrying amount based on their relative fair values. Upon closing of the transaction, OCL became a subsidiary of the Company. The net assets acquired pursuant to the acquisition are as follows:
 
 
Purchase Price
       
         
Issuance of 12,500,000 shares
  $
1,380,427
 
Contingent consideration – warrants
   
414,128
 
Transaction costs
   
54,532
 
         
Total Purchase Price
  $
1,849,087
 
 
Contingent consideration consists of
12,500,000
non-transferable warrants that are exercisable into
12,500,000
common shares if certain criteria are met at an exercise price of
$0.001
for a period of
five
years from the date of issuance expiry
June 4, 2025.
No
share purchase warrants are exercisable until specific performance criteria have been met. Such criteria being
1
) revenue sales projections per OCL's
5
year proformas, or
2
) listing on a major US exchange, or
3
) change of control. The Company has estimated the fair value of the contingent consideration to be
$414,128.
 
 
Purchase Price Allocation
       
         
Cash
  $
114,169
 
Accounts payable and due from related party
   
(232,021
)
Intangible asset
   
1,966,939
 
         
Total Purchase Price
  $
1,849,087
 
 
During the year ended
December 31, 2020,
the Company impaired the intangible asset resulting an expense on the consolidated statement of operations of
$1,966,939.
XML 23 R12.htm IDEA: XBRL DOCUMENT v3.21.1
Note 6 - Common Stock
3 Months Ended
Mar. 31, 2021
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
6.
COMMON STOCK
 
 
The Company has
one
class of
no
par value common stock with
500,000,000
authorized shares
86,522,569
 outstanding on
March 31, 2021
and
December 31, 2020,
respectively.
 
On
June 5, 2020,
the Company issued
12,500,000
shares at a value of
$0.15
CND per share pursuant to the acquisition of OCL Technologies Corp.
 
On
June 5, 2020,
the Company issued
7,000,001
shares to investors, including
1,766,667
common shares to a consultant and directors at
$0.15
CND per share.
XML 24 R13.htm IDEA: XBRL DOCUMENT v3.21.1
Note 7 - Stock Options
3 Months Ended
Mar. 31, 2021
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]
7.
STOCK OPTIONS
  
 
During the period ended
March 31, 2021
and year ended
December 31, 2020,
the Company adopted a Rolling Stock Option Plan. Up to
10%
of the Company's issued and outstanding common shares
may
be reserved for granting of stock options.
 
During the period ended
March 31, 2021,
the Company:
 
i) granted
500,000
stock options to consultants, exercisable into
500,000
shares at an exercise price of
$1.20CND
and an expiry date of
January 29, 2024.
The options have a fair value of
$424,300CND,
calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of
125%;
(ii) Term of
3
years; (iii) Discount rate of
0.14%;
(iv) Dividend rate of
Nil;
and (v) market stock price of
$1.18.
The options vest
20%
every
6
months starting
July 29, 2021.
During the period ended
March 31, 2021,
the Company recorded
$65,035CND
(
$51,351US
) of stock-based compensation relating to the vesting period.
 
During the year ended
December 31, 2020,
the Company:
 
i) granted
3,600,000
stock options to consultants, directors and officers exercisable into
3,600,000
shares at an exercise price of
$0.35CND
and an expiry date of
July 21, 2023.
The options have a fair value of
$909,900CND,
calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of
125%;
(ii) Term of
3
years; (iii) Discount rate of
0.27%;
(iv) Dividend rate of
Nil;
and (v) market stock price of
$0.35.
The options vest
20%
every
6
months starting
January 21, 2020.
During the year ended
December 31, 2020,
the Company recorded
$369,597CND
(
$283,307US
) of stock-based compensation relating to the vesting period. During the period ended
March 31, 2021,
the Company recorded
$135,829CND
(
$107,249US
) of stock-based compensation relating to the vesting period.
 
ii) granted
250,000
stock options to consultants, directors and officers exercisable into
250,000
shares at an exercise price of
$0.45CND
and an expiry date of
December 21, 2023.
The options have a fair value of
$75,800CND,
calculated using the Black-Scholes option pricing model using the following inputs (i) Volatility of
125%;
(ii) Term of
3
years; (iii) Discount rate of
0.02%;
(iv) Dividend rate of
Nil;
and (v) market stock price of
$0.425.
The options vest
20%
every
6
months starting
June 21, 2021.
During the year ended
December 31, 2020,
the Company recorded
$1,899CND
(
$1,486US
) of stock-based compensation relating to the vesting period. During the period ended
March 31, 2021,
the Company recorded
$23,925CND
(
$18,890US
) of stock-based compensation relating to the vesting period.
XML 25 R14.htm IDEA: XBRL DOCUMENT v3.21.1
Note 8 - COVID-19
3 Months Ended
Mar. 31, 2021
COVID-19 [Member]  
Notes to Financial Statements  
Unusual or Infrequent Items, or Both, Disclosure [Text Block]
8.
COVID-
19
  
 
In early
2020,
a coronavirus that causes COVID-
19
emerged globally, which is currently affecting the global economies and has a resulting effect on the Company.  Therefore, while the Company expects this matter to negatively impact the Company's financial condition, results of operations, or cash flows, the extent of the financial impact and duration cannot be reasonably estimated at this time.
XML 26 R15.htm IDEA: XBRL DOCUMENT v3.21.1
Note 9 - Subsequent Event
3 Months Ended
Mar. 31, 2021
Notes to Financial Statements  
Subsequent Events [Text Block]
9.
SUBSEQUENT EVENT
  
 
Subsequent to
March 31, 2021,
the Company closed a non-brokered private placement financing of
4,900,000
units of the Company at a price of
CDN$0.80
per unit for gross proceeds of
CDN$3,920,000.
Each unit consisted of
one
common share of the Company and
one
common share purchase warrant, with each warrant entitling the holder to acquire
one
additional common share of the Company at an exercise price of CDN
$1.00
for a period of
24
months from the date of closing. The expiry date of the warrants
may
be accelerated at the Company's discretion if, the closing price of the Shares on the TSX Venture Exchange is equal to or greater than CDN
$2.50
for a minimum of
ten
consecutive trading days and a notice of acceleration is provided in accordance with the terms of the warrant.
XML 27 R16.htm IDEA: XBRL DOCUMENT v3.21.1
Note 3 - Prepaid Expenses and Other Current Assets (Tables)
3 Months Ended
Mar. 31, 2021
Notes Tables  
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]
   
March 31,
2021
   
December 31,
2020
 
                 
Prepaid expenses
  $
1,000
    $
1,030
 
Tax Receivable – Canadian GST
   
1,801
     
5,052
 
    $
2,801
    $
6,082
 
XML 28 R17.htm IDEA: XBRL DOCUMENT v3.21.1
Note 4 - Accounts Payable and Accrued Expenses (Tables)
3 Months Ended
Mar. 31, 2021
Notes Tables  
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]
   
March 31,
2021
   
December 31,
2020
 
                 
Accounts payable
  $
53,578
    $
16,670
 
Accrued fees and expenses
   
-
     
15,659
 
    $
53,578
    $
32,329
 
XML 29 R18.htm IDEA: XBRL DOCUMENT v3.21.1
Note 5 - Acquisition of OCL Technologies Corp. (Tables)
3 Months Ended
Mar. 31, 2021
Notes Tables  
Schedule of Business Acquisitions, by Acquisition [Table Text Block]
 
Purchase Price
       
         
Issuance of 12,500,000 shares
  $
1,380,427
 
Contingent consideration – warrants
   
414,128
 
Transaction costs
   
54,532
 
         
Total Purchase Price
  $
1,849,087
 
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]
 
Purchase Price Allocation
       
         
Cash
  $
114,169
 
Accounts payable and due from related party
   
(232,021
)
Intangible asset
   
1,966,939
 
         
Total Purchase Price
  $
1,849,087
 
XML 30 R19.htm IDEA: XBRL DOCUMENT v3.21.1
Note 2 - Going Concern (Details Textual) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Net Income (Loss) Attributable to Parent, Total $ (393,620) $ (73,269) $ (2,772,484) $ (192,865)
Retained Earnings (Accumulated Deficit), Ending Balance (44,552,800)   $ (44,159,180)  
Working Capital (Deficit) $ 112,075      
XML 31 R20.htm IDEA: XBRL DOCUMENT v3.21.1
Note 3 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Prepaid expenses $ 1,000 $ 1,030
Tax Receivable – Canadian GST 1,801 5,052
Prepaid Expense and Other Assets, Current $ 2,801 $ 6,082
XML 32 R21.htm IDEA: XBRL DOCUMENT v3.21.1
Note 4 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Accounts payable $ 53,578 $ 16,670
Accrued fees and expenses 15,659
Accounts Payable and Accrued Liabilities, Current, Total $ 53,578 $ 32,329
XML 33 R22.htm IDEA: XBRL DOCUMENT v3.21.1
Note 5 - Acquisition of OCL Technologies Corp. (Details Textual) - USD ($)
12 Months Ended
Dec. 31, 2020
Mar. 31, 2021
Warrants and Rights Outstanding $ 414,128 $ 414,128
Impairment of Intangible Assets (Excluding Goodwill), Total $ 1,966,939  
OCL Technologies Corp [Member]    
Business Acquisition, Percentage of Voting Interests Acquired 100.00%  
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares (in shares) 12,500,000  
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable $ 1,380,427  
Warrants and Rights Outstanding 414,128  
OCL Technologies Corp [Member] | Warrants Issued in Connection With Business Acquisition [Member]    
Business Combination, Consideration Transferred, Equity Interests Issued and Issuable $ 414,128  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) 12,500,000  
Warrants and Rights Outstanding $ 414,128  
Class of Warrant or Right, Outstanding (in shares) 12,500,000  
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) $ 0.001  
Warrants and Rights Outstanding, Term (Year) 5 years  
XML 34 R23.htm IDEA: XBRL DOCUMENT v3.21.1
Note 5 - Acquisition of OCL Technologies Corp. - Purchase Price (Details) - OCL Technologies Corp [Member]
12 Months Ended
Dec. 31, 2020
USD ($)
Issuance of 12,500,000 shares $ 1,380,427
Transaction costs 54,532
Total Purchase Price 1,849,087
Warrants Issued in Connection With Business Acquisition [Member]  
Issuance of 12,500,000 shares $ 414,128
XML 35 R24.htm IDEA: XBRL DOCUMENT v3.21.1
Note 5 - Acquisition of OCL Technologies Corp. - Purchase Price (Details) (Parentheticals)
12 Months Ended
Dec. 31, 2020
shares
OCL Technologies Corp [Member]  
Shares issued (in shares) 12,500,000
XML 36 R25.htm IDEA: XBRL DOCUMENT v3.21.1
Note 5 - Acquisition of OCL Technologies Corp. - Purchase Price Allocation (Details) - OCL Technologies Corp [Member]
Dec. 31, 2020
USD ($)
Cash $ 114,169
Accounts payable and due from related party (232,021)
Intangible asset 1,966,939
Total Purchase Price $ 1,849,087
XML 37 R26.htm IDEA: XBRL DOCUMENT v3.21.1
Note 6 - Common Stock (Details Textual)
Jun. 05, 2020
$ / shares
shares
Mar. 31, 2021
$ / shares
shares
Dec. 31, 2020
$ / shares
shares
Common Stock, No Par Value (in dollars per share) | $ / shares   $ 0 $ 0
Common Stock, Shares Authorized (in shares)   500,000,000 500,000,000
Common Stock, Shares, Outstanding, Ending Balance (in shares)   86,522,569 86,522,569
OCL Technologies Corp [Member]      
Stock Issued During Period, Shares, New Issues (in shares) 12,500,000    
Shares Issued, Price Per Share (in CAD per share) | $ / shares $ 0.15    
Investors [Member]      
Stock Issued During Period, Shares, New Issues (in shares) 7,000,001    
Shares Issued, Price Per Share (in CAD per share) | $ / shares $ 0.15    
Employee and Directors [Member]      
Stock Issued During Period, Shares, New Issues (in shares) 1,766,667    
Shares Issued, Price Per Share (in CAD per share) | $ / shares $ 0.15    
XML 38 R27.htm IDEA: XBRL DOCUMENT v3.21.1
Note 7 - Stock Options (Details Textual)
3 Months Ended 12 Months Ended
Jan. 29, 2021
CAD ($)
$ / shares
shares
Dec. 21, 2020
CAD ($)
$ / shares
shares
Jul. 21, 2020
CAD ($)
$ / shares
shares
Mar. 31, 2021
USD ($)
Mar. 31, 2021
CAD ($)
Mar. 31, 2020
USD ($)
Dec. 31, 2020
USD ($)
Dec. 31, 2020
CAD ($)
Share-based Payment Arrangement, Expense | $       $ 177,490      
Rolling Stock Option Plan [Member]                
Share-based Compensation Arrangement, Percent of Issued and Outstanding Common Shares Reserved       10.00% 10.00%   10.00% 10.00%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares) | shares 500,000 250,000 3,600,000          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in shares) | shares 500,000 250,000 3,600,000          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in CAD per share) | $ / shares $ 1.20 $ 0.45 $ 0.35          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Fair Value | $ $ 424,300 $ 75,800 $ 909,900          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price (in CAD per share) | $ / shares $ 1.18 $ 0.425 $ 0.35          
Rolling Stock Option Plan [Member] | Share-based Payment Arrangement, Option [Member]                
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 125.00% 125.00% 125.00%          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term (Year) 3 years 3 years 3 years          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Discount for Postvesting Restrictions 0.14% 0.02% 0.27%          
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 0.00% 0.00% 0.00%          
Rolling Stock Option Plan [Member] | Share-based Payment Arrangement, Option [Member] | January 2021 [Member]                
Share-based Payment Arrangement, Expense       $ 51,351 $ 65,035      
Rolling Stock Option Plan [Member] | Share-based Payment Arrangement, Option [Member] | July 2020 [Member]                
Share-based Payment Arrangement, Expense       107,249 135,829   $ 283,307 $ 369,597
Rolling Stock Option Plan [Member] | Share-based Payment Arrangement, Option [Member] | December 2020 [Member]                
Share-based Payment Arrangement, Expense       $ 18,890 $ 23,925   $ 1,486 $ 1,899
Rolling Stock Option Plan [Member] | Share-based Payment Arrangement, Option [Member] | Share-based Payment Arrangement, Tranche One [Member]                
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage 20.00% 20.00% 20.00%          
XML 39 R28.htm IDEA: XBRL DOCUMENT v3.21.1
Note 9 - Subsequent Event (Details Textual)
1 Months Ended
May 12, 2021
CAD ($)
$ / shares
shares
Warrants Issued in Connection with Private Placement [Member]  
Equity Offering, Number of Warrants Per Unit (in shares) 1
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right (in shares) 1
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares $ 1
Warrants and Rights Outstanding, Term (Year) 2 years
Class of Warrant of Right, Stock Price Trigger (in CAD per share) | $ / shares $ 2.50
Class of Warrant or Right, Threshold Consecutive Trading Days 10
Private Placement [Member]  
Equity Offering, Number of Units Issued (in shares) 4,900,000
Equity Offering, Price Per Unit Issued (in CAD per share) | $ / shares $ 0.80
Proceeds from Issuance or Sale of Equity, Total | $ $ 3,920,000
Equity Offering, Number of Common Shares Per Unit (in shares) 1
EXCEL 40 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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

:48+7 K0%9Y3L2W%3)^ M6#B^\_W%![K/E'GA+N,5JD_E5NB9VZ*D-,="4EZ P-W".?=?;?S0.%B+ MSQ0/LC,&(^6:\QLSN4@7CF<8(<-$&0BB'[>X1L8,DN;Q=P/JM#&-8W?\'?V- M%:_%7!.):\Z^T%1E"V?F0(H[4C'U@1_^P$909/ 2SJ2]PZ&VC4,'DDHJGC?. MFD%.B_I)[II$=!Q"[Q&'H'$(ACJ$C4,XU&'2.$QL9FHI-@\;HLAR+O@!A+'6 M:&9@DVF]M7Q:F+I?*:&_4NVGEI=<(<3P.ZQYGNLZ7"F>W,"+#2I"F82/>*K+MZQGYTFN6L M93GK97E1W*+>P?5"'U"@LQ;T[!<6Z.Q!@::V//YIY;YW/%>\7URA)N"P$OF= M ]#O)?HZ+QG_A@AZ1X -%;HA&5@Q_W@:^/W'P?];LR;8O54UC?4U?207QPW? M[]_Q?T+1PB%%YIKKG2'9(>9 M[GI1& /]?<=U7]-,3)O4]M'+_P!02P,$% @ M'VL4K]%1\)W!0 2QP M !D !X;"]W;W)K&ULQ5EA;YLZ%/TK5K0G;5(7 ML D!IC12&]:UD[I%[=;IZ>E]<(G3H '.LTW22OOQSP9*0C"$ILK6#XV!>P[7 MYUY\KV&TINPG7Q BP&,<)?RTMQ!B^<$P>+ @,>9]NB2)O#*G+,9"'K('@R\9 MP;,,%$<&,LVA$>,PZ8U'V;DI&X]H*J(P(5,&>!K'F#V=DXBN3WNP]WSB)GQ8 M"'7"&(^6^('<$O%].67RR"A99F%,$A[2!# R/^V=P0]7""E 9G$7DC7?&@,U ME7M*?ZJ#J]EISU0>D8@$0E%@^;,B$Q)%BDGZ\5]!VBOOJ8#;XV?VBVSR"%(N:%R I0=Q MF.2_^+$08@M@.0T 5 !05X!5 *RN@$$!&.P $&P V 7 [@H8%H!A5X!3 )RN M +< N%T!7@'PLG3(XY<%W\<"CT>,K@%3UI)-#;(,RM RYF&BDOU6,'DUE#@Q M_D(% 0YX#VX%#7Z"KTN5@AR\]8G 8<3!-_(H4AR]&QE"WDUAC*!@/L^940/S M9YST ?). #(1G)SYX.V;=V^ ?@",\+S_QK623NK3P+)"C-6LSNKO\?7-#J$ M]6,[ZS5F?6#EK/#[;<:J8;EX 4OAFX;E4W<6L]F7RP[J[V>Y>@&+=D:&S.(R ME5&9RBBC'330WJHPO5+#Z>I MM,7)#'Q-!1=RH)R4V%BB,CH.;G(=9CK1V_V!9M\T_](],P?B+@_$7;T<5PF M70; ?G4 P/T3T.;Z&K/9R?,2?@(^283@($Q4P$(Z4V_DH]"X MN)WGGMI;SX-MJK_J\S"IFR&[;N;7S:QAE:XBV+ 4;/C;!/OX*!,[Y/@^(B?@ M2ZH>JLYB#;N)53?3BE4W:Q7+*<5R_HQ8/[*>4EJ?K0B3/?+S50*F+ Q(IJ): MZ)=2T4Q#)>:FP.H$S6?B;J_&?;2C9MW&[ _L'2UU1I:M%](MA71_FY 7.&3@ M#D=I4V$Z=VN%:8 &5BVWZF:.[=92JV[EF9[7E%E>*8AW;$&V=#B3527>2;17 MI)*G227H[JB7&SG57$*[R52G:DXF:&YZXE1'9#W9XBR5OQ$6 M@[=_$\ST>[EV#RWP))'Z_=JA2/\09%7A3?,,V[OG(RKLASR@J;2;4P:FE(L5 MX4(]S;+M%7+)RLRTDK>[;/;A0)_2^W FTB?T/AQR6M-YLXF K]]%O#:=_7 5 MSHC<=C0N&>T^-C7ZDP-Q_LMQ574W.P38OD4X2K&0D,\X23%[REXS="HBFQ8= M=N_1VS;FVC-,RPO6,^FMAIE"EM=E)ZTY;" M[GWIBY5V:YL.:#IHX.U*K;&S;!?MV%W">J>)7,LRG:K=E<;.&GJVYS3$;M.2 MPO:>]%BQ\TF0C3O'#VT:0=3>"+XF?@5UY?V5Z^Z^OKK0F"'+VVUT+W5L W>X M$SOM/3U/'SFTZ3I1>V]UK,CMA7R3XV!!P->$= KLUJO)HW=XV0^X>VXNU(:; ME^_BY)Y;5P3W>(4:J^"A0/\ 8"ZIL?4-0WUFN\;L(4PXB,A<,IE]1RXX+/]R ME1\(NLP^:]Q3(6B<#1<$SPA3!O+ZG%+Q?*"^E)3?#\?_ U!+ P04 " "T M?:Q2,/9;A)0# F"P &0 'AL+W=OHOZ_GTJS\6DM"<^2*"@X2T[%W$WZZ#;M6P.WX ME^)6->[!NK(4XM$N/B=C+[!$R##65@4Q?QN<(F-6D^%XJI1ZM4TKV+S?:__; M.6^<61*%4\%^T$1G8V_@08(I*9C^)K;_8.50S^J+!5/N"MMJ;^!!7"@M\DK8 M$.24E__DN0I$0Z#3/R$050*1XRX-.G&'FE"FX &?=4'8Y'R M _B@,B)1E=<6*YTZ)AUGI7O"R@\B)>%:P6>E"DR L>\R7*_UKL=VO[W5;[LZ>"ZAU\35.4E*\^PI?"J@:10HTV-^OO MG)K/9.A*SX]^H-)2SUFR)W0S"4?^Y@A[])N5X$\$8 MD0K6QEO'?@F_X9"(Q_PHH?JO^W%=^W']MB0E/-FS?2VTTF;MDN8!90X7/Y'( MHX%MUQ[!S@BV':9!S3EX9[S3?;P76L2/5; ?)%VM3#AM>.W)?D=H2_N#1FBC MJ][QX YKZ.&Y2?*0&8Q,L,36!&7RW'85@T]LU.&.[(XR#E^F<7 <,0P.E3MH MA3RK!H6-QA">6X5LX:FKXRL'N++2=+T[#.SOA/_1 3!Z'V"9275E;/"],Z,J MP\V4"JX&)W@/725L;RMS*6+$1$$J1>[H"+=E1L*",%=N2H],C@E-F*4\"M=Y M44HZPZ@EH(>V$Y[==Z8BSTWO6[B0O;GYA*]W'[\QNN0H5VY 4Q"+@NMRBJF? MUD/@33GZ'+:7$^0]D2O*%3!,C6AP=6WLRG(H*Q=:K-T@M!3:C%7N-C.#+$J[ MP;Q/A1F&JH4U4(_&D_\!4$L#!!0 ( +1]K%+Y\BYS"P, (L0 - M>&POWW./[XX8==;H#:?7*TJUMZZX:%)_ MI77],0B:Y8I6I#F7-14&*:2JB#93509-K2C)&W"J># >C>*@(DSX\YEHJ\M* M-]Y2MD*G?C28/'O[DJ=^&+_W/4N7R9RF_NWIVY^MU!=O/'L_>7=R,KH]NSBV MGW; F1\X22=/(#T?C7!B #'R^&GDCW%WU$&?H/FLD.(P3V PL4E%O3O"4S\C MG"T4 Z^"5(QOK'D,AJ7D4GG:%,B("<'2W%LXM#.H7<]3,2%5%]M&L-^+?OD1 ML)V!0,;Y('#L6\-\5A.MJ1*79M(M[HP/(*\?WVQJH[!49!..)_[.H;N9( NI M&=DDYOX;&_E$< M<*^+O:J.H*9B&!I!_=#2V GP[[-9[CW:Y%FT7LWNI/[:_F^>2"JH(WQ=M6O\E9_G9BJ,/_TIR]Z-R+-BI ML3^L7KK(R6L0&;](D4'_@[YW:AR<&8/5@[,Y];_#>P#?!?46+>.:B7ZV8GE. MQ8.CP]!KLC!O6@?\9GU."])R?3. J;\;?Z,Y:ZMD6'4%B>A7[<9?87MA/+P8 MF%A,Y'1-\ZR?JG+1#3TS,%'["QR.D@?BN^- 3[E]H@BJBFG#GF <21(,@5YT]V@<(]F)X>.N#_:41%&2N!' W JB M"$/@:<013 %HP) HZL[!H_,HV)Y3P>[?#_/?4$L#!!0 ( +1]K%*7BKL< MP !," + 7W)E;',O+G)E;'.=DKENPS ,0'_%T)XP!] AB#-E\18$ M^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE [3BDMHNI&/T04FE:U;@!2+8E MCVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G.L?DTJ9J*G5)UT6JEFBI^CH1FS2H&%S O?WZ';"RXK5&>S%]B_1< M4E/R% \&D[0D3"3G9X>QUBKU"]+0W# IH-)6W#+ZI-_:;1$],LVVC#/S,DO< M?TX35#+!2O9*BUDR2)#>RZ'^0?!CDG>N]!3@*0DWXA?T)V1!DZ0M^(9HYMK:B&>UQ7?^,Y#0 .8T .0+( MBSR7M5V$:_)" ,%!7O@Y?!!*XH,(F&.'^5##T]T2M(EG?HUNJ+^MLZ!K>I:- MPYP YER6)1#:E'/OPX422]6P71W=B0[>Z72Z. MLJD/%A)*UK-1'-C4AJW>:OI0VP//Y2/\^H AF60]VR289UJ'ARRDDRR&3[HR M31LS))0LAE&Z,DT;,^26+(9J07;(8>NEL\.60C'L-"[0]!'>1.'+(1C6.BC0T=#ZF.&+(2=A=+# MIZ""[IB@Q4]XA(;ZG/!\K9"]-(?3T=C*8E=S/H>ZE;B6I#A\63I\%3O_ U!+ M P04 " "T?:Q2+P""5$P! !K$0 &@ 'AL+U]R96QS+W=OR@^FG MD]*.7>ZGY5CI(2^N>64TQW&JQ^<9ZGAXGAF=[X/YST1;EDUA/FWQW9G>_S%8 M_]CQZFICO(K.^5@9GRE]:Y=MI^<'K:;)*CI=,C6>+J1TZ""&( X?E$!0$CYH M#4'K\$$;"-J$#THA* T?M(6@;?B@'03MP@?M(6@?/HABE#$6D/2"M0"M";DF M 5X3@DT"Q"8DFP2838@V"5";D&T2X#8AW"1 ;D*Z28#=A'B3 +T9]68!>C/J MS0+TYI>/;0%Z,^K- O1FU)L%Z,VH-PO0FU%O%J WH]XL0&]&O?F=>CM_;XU; M>AYKO/^=5/OI7;-7!E&ULS9C+3L,P$$5_)J7;+>T?\\D?4B@$E$5B=G$2CQS[[5'.HM,WK8>8K8Q MVL9IWJ3D'QB+90-&QL)YL+A3NV!DPM>P8%Z62[D )D:C,2N=36#3,+4:^6SR M!+5ZU*F7"?K6WUS66X=RBPLZN)C?)Q M@ 4Y.^G0[OQLL.][74,(JH)L+D-ZD0:KV$:SF+8:8M$O<2*CJVM50N7*E<&6 M(OH LHH-0#*ZV(D.^IT3WC#LGOQB_TZFSQ KY\'YB!,+<+[=821M]]"C$(2D M^H]X=$3IB\\'[;0KJ'[IC=?[X<*RFT=DW7+Y'7^=\5'_S!R"2(XK(CFNB>2X M(9)C3"3'+9$<=T1RW!/)P4=4@E A*J>"5$Z%J9P*5#D5JG(J6.54N,JI@)53 M(:N@0E9!A:R""ED%%;(**F055,@JJ)!54"&K^$^ROCNW_.N_&>U:&*GLP9]U MOXQFGU!+ 0(4 Q0 ( +1]K%('04UB@0 +$ 0 " M 0 !D;V-0&UL4$L! A0#% @ M'VL4NTW.RWO M*P( !$ ( !KP &1O8U!R;W!S+V-O&UL4$L! A0# M% @ M'VL4IE&PO=V]R:W-H965T&UL4$L! A0# M% @ M'VL4K6;7G-0! FPX !@ ("!20P 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ M'VL4J$I__(+ M! N! !@ ("!WA< 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M'VL4@F Q'[* @ V 4 !@ M ("!2B0 'AL+W=O&PO=V]R:W-H965T6 , X' 9 " @38M !X;"]W M;W)K&UL4$L! A0#% @ M'VL4BG6G.1R @ M)@4 !D ("!Q3 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M'VL4NH4];]( @ X00 !D M ("!33D 'AL+W=OG<" T!0 &0 @(',.P >&PO=V]R:W-H M965TS5@( !H% 9 M " @7H^ !X;"]W;W)K&UL4$L! M A0#% @ M'VL4MU=VI3_ @ Q@8 !D ("!!T$ 'AL M+W=O&PO=V]R:W-H965T_=2@( *T% 9 " M@4I' !X;"]W;W)K&UL4$L! A0#% @ M'VL M4K!5L<50 @ T@4 !D ("!RTD 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M'VL4D]#=Q8G @ D 0 M !D ("!25, 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M'VL4K]%1\)W!0 2QP !D M ("!J5L 'AL+W=O&PO=V]R:W-H965T M* MNQS $P( L ( !6&@ %]R96QS+RYR96QS4$L! A0# M% @ M'VL4@;R(VX% P F1, \ ( !06D 'AL+W=O MP$ #H2 3 " ?=M !;0V]N=&5N B=%]4>7!E&UL4$L%!@ D "0 LPD *-O $! end XML 41 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 42 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 43 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 61 194 1 false 17 0 false 6 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.oculusvisiontech.com/20210331/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Interim Consolidated Balance Sheets (Current Period Unaudited) Sheet http://www.oculusvisiontech.com/20210331/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited Condensed Interim Consolidated Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Interim Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://www.oculusvisiontech.com/20210331/role/statement-condensed-interim-consolidated-balance-sheets-current-period-unaudited-parentheticals Condensed Interim Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations (Unaudited) Sheet http://www.oculusvisiontech.com/20210331/role/statement-consolidated-statements-of-operations-unaudited Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://www.oculusvisiontech.com/20210331/role/statement-consolidated-statements-of-stockholders-equity-unaudited Consolidated Statements of Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://www.oculusvisiontech.com/20210331/role/statement-consolidated-statements-of-cash-flows-unaudited Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Basis of Presentation and Business Sheet http://www.oculusvisiontech.com/20210331/role/statement-note-1-basis-of-presentation-and-business Note 1 - Basis of Presentation and Business Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Going Concern Sheet http://www.oculusvisiontech.com/20210331/role/statement-note-2-going-concern Note 2 - Going Concern Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Prepaid Expenses and Other Current Assets Sheet http://www.oculusvisiontech.com/20210331/role/statement-note-3-prepaid-expenses-and-other-current-assets Note 3 - Prepaid Expenses and Other Current Assets Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Accounts Payable and Accrued Expenses Sheet http://www.oculusvisiontech.com/20210331/role/statement-note-4-accounts-payable-and-accrued-expenses Note 4 - Accounts Payable and Accrued Expenses Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Acquisition of OCL Technologies Corp. Sheet http://www.oculusvisiontech.com/20210331/role/statement-note-5-acquisition-of-ocl-technologies-corp Note 5 - Acquisition of OCL Technologies Corp. Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Common Stock Sheet http://www.oculusvisiontech.com/20210331/role/statement-note-6-common-stock Note 6 - Common Stock Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Stock Options Sheet http://www.oculusvisiontech.com/20210331/role/statement-note-7-stock-options Note 7 - Stock Options Notes 13 false false R14.htm 013 - Disclosure - Note 8 - COVID-19 Sheet http://www.oculusvisiontech.com/20210331/role/statement-note-8-covid19 Note 8 - COVID-19 Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Subsequent Event Sheet http://www.oculusvisiontech.com/20210331/role/statement-note-9-subsequent-event Note 9 - Subsequent Event Notes 15 false false R16.htm 015 - Disclosure - Note 3 - Prepaid Expenses and Other Current Assets (Tables) Sheet http://www.oculusvisiontech.com/20210331/role/statement-note-3-prepaid-expenses-and-other-current-assets-tables Note 3 - Prepaid Expenses and Other Current Assets (Tables) Tables http://www.oculusvisiontech.com/20210331/role/statement-note-3-prepaid-expenses-and-other-current-assets 16 false false R17.htm 016 - Disclosure - Note 4 - Accounts Payable and Accrued Expenses (Tables) Sheet http://www.oculusvisiontech.com/20210331/role/statement-note-4-accounts-payable-and-accrued-expenses-tables Note 4 - Accounts Payable and Accrued Expenses (Tables) Tables http://www.oculusvisiontech.com/20210331/role/statement-note-4-accounts-payable-and-accrued-expenses 17 false false R18.htm 017 - Disclosure - Note 5 - Acquisition of OCL Technologies Corp. (Tables) Sheet http://www.oculusvisiontech.com/20210331/role/statement-note-5-acquisition-of-ocl-technologies-corp-tables Note 5 - Acquisition of OCL Technologies Corp. (Tables) Tables http://www.oculusvisiontech.com/20210331/role/statement-note-5-acquisition-of-ocl-technologies-corp 18 false false R19.htm 018 - Disclosure - Note 2 - Going Concern (Details Textual) Sheet http://www.oculusvisiontech.com/20210331/role/statement-note-2-going-concern-details-textual Note 2 - Going Concern (Details Textual) Details http://www.oculusvisiontech.com/20210331/role/statement-note-2-going-concern 19 false false R20.htm 019 - Disclosure - Note 3 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) Sheet http://www.oculusvisiontech.com/20210331/role/statement-note-3-prepaid-expenses-and-other-current-assets-summary-of-prepaid-expenses-and-other-current-assets-details Note 3 - Prepaid Expenses and Other Current Assets - Summary of Prepaid Expenses and Other Current Assets (Details) Details 20 false false R21.htm 020 - Disclosure - Note 4 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details) Sheet http://www.oculusvisiontech.com/20210331/role/statement-note-4-accounts-payable-and-accrued-expenses-summary-of-accounts-payable-and-accrued-expenses-details Note 4 - Accounts Payable and Accrued Expenses - Summary of Accounts Payable and Accrued Expenses (Details) Details 21 false false R22.htm 021 - Disclosure - Note 5 - Acquisition of OCL Technologies Corp. (Details Textual) Sheet http://www.oculusvisiontech.com/20210331/role/statement-note-5-acquisition-of-ocl-technologies-corp-details-textual Note 5 - Acquisition of OCL Technologies Corp. (Details Textual) Details http://www.oculusvisiontech.com/20210331/role/statement-note-5-acquisition-of-ocl-technologies-corp-tables 22 false false R23.htm 022 - Disclosure - Note 5 - Acquisition of OCL Technologies Corp. - Purchase Price (Details) Sheet http://www.oculusvisiontech.com/20210331/role/statement-note-5-acquisition-of-ocl-technologies-corp-purchase-price-details Note 5 - Acquisition of OCL Technologies Corp. - Purchase Price (Details) Details 23 false false R24.htm 023 - Disclosure - Note 5 - Acquisition of OCL Technologies Corp. - Purchase Price (Details) (Parentheticals) Sheet http://www.oculusvisiontech.com/20210331/role/statement-note-5-acquisition-of-ocl-technologies-corp-purchase-price-details-parentheticals Note 5 - Acquisition of OCL Technologies Corp. - Purchase Price (Details) (Parentheticals) Details 24 false false R25.htm 024 - Disclosure - Note 5 - Acquisition of OCL Technologies Corp. - Purchase Price Allocation (Details) Sheet http://www.oculusvisiontech.com/20210331/role/statement-note-5-acquisition-of-ocl-technologies-corp-purchase-price-allocation-details Note 5 - Acquisition of OCL Technologies Corp. - Purchase Price Allocation (Details) Details 25 false false R26.htm 025 - Disclosure - Note 6 - Common Stock (Details Textual) Sheet http://www.oculusvisiontech.com/20210331/role/statement-note-6-common-stock-details-textual Note 6 - Common Stock (Details Textual) Details http://www.oculusvisiontech.com/20210331/role/statement-note-6-common-stock 26 false false R27.htm 026 - Disclosure - Note 7 - Stock Options (Details Textual) Sheet http://www.oculusvisiontech.com/20210331/role/statement-note-7-stock-options-details-textual Note 7 - Stock Options (Details Textual) Details http://www.oculusvisiontech.com/20210331/role/statement-note-7-stock-options 27 false false R28.htm 027 - Disclosure - Note 9 - Subsequent Event (Details Textual) Sheet http://www.oculusvisiontech.com/20210331/role/statement-note-9-subsequent-event-details-textual Note 9 - Subsequent Event (Details Textual) Details http://www.oculusvisiontech.com/20210331/role/statement-note-9-subsequent-event 28 false false All Reports Book All Reports ovtz-20210331.xml ovtz-20210331.xsd ovtz-20210331_cal.xml ovtz-20210331_def.xml ovtz-20210331_lab.xml ovtz-20210331_pre.xml http://fasb.org/us-gaap/2020-01-31 http://fasb.org/srt/2020-01-31 http://xbrl.sec.gov/dei/2019-01-31 true true ZIP 45 0001437749-21-011821-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-21-011821-xbrl.zip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end